Annotation Detail for GSTP1
Basic Information Top
| Gene Symbol: | GSTP1 ( DFN7,FAEES3,GST3,GSTP,PI ) |
|---|---|
| Gene Full Name: | glutathione S-transferase pi 1 |
| Band: | 11q13.2 |
| Quick Links | Entrez ID:2950; OMIM: 134660; Uniprot ID:GSTP1_HUMAN; ENSEMBL ID: ENSG00000084207; HGNC ID: 4638 |
| Relate to Another Database: | SFARIGene; denovo-db |
| Pathway ID | Pathway Name |
|---|---|
| PWY-4061 | glutathione-mediated detoxification |
| Pathway ID | Pathway Name |
|---|---|
| hsa00480 | Glutathione metabolism |
| hsa00980 | Metabolism of xenobiotics by cytochrome P450 |
| hsa00982 | Drug metabolism - cytochrome P450 |
| hsa05215 | Prostate cancer |
| hsa05200 | Pathways in cancer |
| Pathway ID | Pathway Name |
|---|---|
| Biological oxidations |
| No data |
| No data |
| No data |
| Desease ID | Desease Name |
|---|---|
| Cancers | |
| Cancers of the urinary system and male genital organs | |
| H00024 | Prostate cancer |
| Desease ID | Desease Name |
|---|---|
| 1739 | Oral cancer |
| 1804 | Chronic obstructive airway disease |
| 1811 | Drug-Induced dyskinesia |
| 1813 | Silicosis |
| 1820 | Kuhnt-Junius degeneration |
| 1826 | Cystic fibrosis |
| 1831 | Prostate cancer |
| 1850 | Herpes |
| 1863 | Aplastic anemia |
| 1869 | Behcet syndrome |
| 1870 | Drug abuse |
| 1901 | Endometriosis |
| 1902 | Kidney failure |
| 1904 | Diabetes mellitus |
| 1932 | Pancreatitis |
| 1934 | Cancer |
| 1942 | Emphysema |
| 1964 | Primary biliary cirrhosis |
| 1979 | Testicular dysfunction |
| 1986 | Eating disorder |
| 2008 | Liver disease |
| 2044 | Pre-Eclampsia |
| 2050 | Peptic esophagitis |
| 2069 | Schizophrenia |
| 2074 | Asthma |
| 2134 | Amyotrophic lateral sclerosis |
| 2164 | Barrett's esophagus |
| 2198 | Psychotic disorder |
| 2207 | Deafness |
| 2220 | Dermatitis |
| Desease Name |
|---|
| oral cancer |
| DNA Damage |
| Parkinson's disease |
| colorectal cancer |
| CHEMDEPENDENCY |
| methamphetamine abuse |
| Rectal Neoplasms |
| CANCER |
| stomach cancer |
| Hematologic Diseases |
| PHARMACOGENOMIC |
| Asthma |
| esophageal cancer |
| arsenic toxicity |
| breast cancer |
| IMMUNE |
| NEUROLOGICAL |
| Total IgE. SPT. FEV1 |
| Adenocarcinoma |
| cystic fibrosis. |
| asbestosis or pleural plaques |
| docetaxel pharmacokinetics docetaxel toxicity |
| METABOLIC |
| metastatic colorectal cancer |
| chronic obstructive pulmonary disease/COPD |
| chemotherapy-induced leukemia |
| lung cancer |
| leukemia |
| DNA adducts |
| psychoses |
| cocaine dependence |
| cytogenetic studies |
| 1-hydroxypyrene, urinary |
| No data |
| No data |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C007318 | 1,2-dibromo-3-chloropropane | GSTP1 protein affects the metabolism of 1,2-dibromo-3-chloropropane | affects metabolic processing | 8242859 |
| C007318 | 1,2-dibromo-3-chloropropane | GSTP1 protein results in increased susceptibility to 1,2-dibromo-3-chloropropane | increases response to substance | 8242859 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GSTP1 mRNA | increases expression | 18692084 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 mRNA | increases expression | 11600134 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 protein | increases expression | 11600134 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 mRNA] | increases expression|increases reaction | 11600134 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 protein] | increases expression|increases reaction | 11600134 |
| C042630 | 1-chloro-2,4-dinitrobenzene-glutathione conjugate | GSTP1 protein affects the metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate | affects metabolic processing | 11684093 |
| C016614 | 1-nitronaphthalene | 1-nitronaphthalene metabolite binds to GSTP1 protein | affects binding | 16453347 |
| C024336 | 1-phenylazo-2-naphthol | 1-phenylazo-2-naphthol results in increased expression of GSTP1 mRNA | increases expression | 2563599 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | 2,3,7,8-tetrachlorodibenzofuran affects the expression of GSTP1 mRNA | affects expression | 18343893 |
| C009497 | 2-(4-toluidino)-6-naphthalenesulfonic acid | 2-(4-toluidino)-6-naphthalenesulfonic acid binds to GSTP1 protein | affects binding | 7725348 |
| C019359 | 2,5-di-tert-butylhydroquinone | 2,5-di-tert-butylhydroquinone results in increased expression of GSTP1 protein | increases expression | 12680784 |
| C024709 | 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone | 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to GSTP1 protein | affects binding | 16533022 |
| C024709 | 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone | 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone results in increased alkylation of and results in decreased activity of GSTP1 protein | decreases activity|increases alkylation | 15606144 |
| C096092 | 2-(acetoxyamino)-1-methyl-6-phenylimidazo(4,5-b)pyridine | GSTP1 protein affects the metabolism of and results in decreased activity of 2-(acetoxyamino)-1-methyl-6-phenylimidazo(4,5-b)pyridine | affects metabolic processing|decreases activity | 8069858 |
| C099328 | 2-allylphenol | 2-allylphenol results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| C099328 | 2-allylphenol | 2-allylphenol results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| C035208 | 2-amino-4,6-dinitrotoluene | 2-amino-4,6-dinitrotoluene affects the expression of GSTP1 mRNA | affects expression | 21346803 |
| C012177 | 2-aminofluorene | 2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein] | increases expression|increases reaction | 19052882 |
| C012177 | 2-aminofluorene | 2-aminofluorene results in increased expression of GSTP1 protein | increases expression | 19052882 |
| C012796 | 2-butenal | 2-butenal binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 9463521 |
| C012796 | 2-butenal | GSTP1 protein results in increased metabolism of 2-butenal | increases metabolic processing | 10799737 |
| C012796 | 2-butenal | 2-butenal results in increased expression of GSTP1 protein | increases expression | 11600134 |
| C004726 | 2-dichlorobenzene | 2-dichlorobenzene affects the localization of GSTP1 protein | affects localization | 18409811 |
| C004726 | 2-dichlorobenzene | 2-dichlorobenzene results in decreased activity of GSTP1 protein | decreases activity | 18409811 |
| C011917 | 2-heptanone | 2-heptanone results in decreased activity of GSTP1 protein | decreases activity | 18409811 |
| C051750 | 2-hexenal | 2-hexenal binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 9463521 |
| C029536 | 2-oxothiazolidine-4-carboxylic acid | 2-oxothiazolidine-4-carboxylic acid results in increased expression of and results in increased activity of GSTP1 protein | increases activity|increases expression | 16950796 |
| C082398 | 2-S-glutathionylcaffeic acid | 2-S-glutathionylcaffeic acid results in decreased activity of GSTP1 protein | decreases activity | 8340025 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of GSTP1 mRNA | increases expression | 17961207 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of GSTP1 mRNA | increases expression | 15533597 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of GSTP1 protein | increases expression | 12680784 |
| C527796 | 3-morpholinopropyl isothiocyanate | 3-morpholinopropyl isothiocyanate results in increased expression of GSTP1 mRNA | increases expression | 20498004 |
| C527796 | 3-morpholinopropyl isothiocyanate | 3-morpholinopropyl isothiocyanate results in increased expression of GSTP1 protein | increases expression | 20498004 |
| C035207 | 4-amino-2,6-dinitrotoluene | 4-amino-2,6-dinitrotoluene affects the expression of GSTP1 mRNA | affects expression | 21346803 |
| C010407 | 4-chloronitrobenzene | GSTP1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 8973562 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 9463521 |
| C027576 | 4-hydroxy-2-nonenal | GSTP1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal | decreases response to substance | 15829614 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased expression of GSTP1 protein | increases expression | 11600134 |
| C403894 | 4-oxo-2-nonenal | GSTP1 protein affects the metabolism of [4-oxo-2-nonenal co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 15528046 |
| C099327 | 4-propylphenol | 4-propylphenol results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| C099327 | 4-propylphenol | 4-propylphenol results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| C029351 | 4-vinylpyridine | GSTP1 protein affects the metabolism of 4-vinylpyridine | affects metabolic processing | 15882759 |
| C086396 | 5-S-glutathionyl-alpha-methyldopa | 5-S-glutathionyl-alpha-methyldopa results in decreased activity of GSTP1 protein | decreases activity | 8131222 |
| C086394 | 5-S-glutathionyldopamine | 5-S-glutathionyldopamine results in decreased activity of GSTP1 protein | decreases activity | 8131222 |
| C122155 | 6-bromoacetyl-2-dimethylaminonaphthalene | GSTP1 protein affects the metabolism of [6-bromoacetyl-2-dimethylaminonaphthalene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 12470677 |
| C478192 | 6-chloroacetyl-2-dimethylaminonaphthalene | GSTP1 protein affects the metabolism of 6-chloroacetyl-2-dimethylaminonaphthalene | affects metabolic processing | 12470677 |
| C111984 | 6-methylsulfinylhexyl isothiocyanate | 6-methylsulfinylhexyl isothiocyanate results in increased expression of GSTP1 protein | increases expression | 11706044 |
| C008450 | 7-methylguanine | GSTP1 gene polymorphism affects the susceptibility to and affects the metabolism of 7-methylguanine | affects metabolic processing|affects response to substance | 15066569 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of GSTP1 mRNA | affects expression | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of GSTP1 mRNA | decreases expression | 16611625 |
| D000082 | Acetaminophen | SLC13A1 protein affects the reaction [Acetaminophen results in increased expression of GSTP1 mRNA] | affects reaction|increases expression | 16729303 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of GSTP1 mRNA | increases expression | 11779202 |
| D015250 | Aclarubicin | Aclarubicin promotes the reaction [GATA1 protein binds to GSTP1 promoter] | affects binding|increases reaction | 14623254 |
| D015250 | Aclarubicin | Aclarubicin results in increased expression of GSTP1 mRNA | increases expression | 14623254 |
| D015250 | Aclarubicin | Aclarubicin results in increased expression of GSTP1 protein | increases expression | 14623254 |
| D000165 | Acridine Orange | [Acridine Orange binds to Platinum Compounds] which results in increased expression of GSTP1 mRNA | affects binding|increases expression | 16814760 |
| D000165 | Acridine Orange | [Acridine Orange binds to Platinum] which results in increased expression of GSTP1 mRNA | affects binding|increases expression | 16814760 |
| D000171 | Acrolein | Acrolein binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 9463521 |
| D000171 | Acrolein | GSTP1 protein polymorphism results in increased metabolism of Acrolein | increases metabolic processing | 10799737 |
| D000171 | Acrolein | GSTP1 protein results in increased metabolism of Acrolein | increases metabolic processing | 10799737 |
| D000171 | Acrolein | Acrolein results in increased expression of GSTP1 protein | increases expression | 11600134 16242832 |
| D020106 | Acrylamide | Acrylamide results in increased expression of GSTP1 mRNA | increases expression | 17961207 |
| D020106 | Acrylamide | Acrylamide results in increased expression of GSTP1 mRNA | increases expression | 15749267 |
| C038518 | acrylodan | GSTP1 protein affects the metabolism of [acrylodan co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 12470677 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of GSTP1 promoter | increases methylation | 15808399 |
| C006426 | aflatoxin B1-2,3-oxide | GSTP1 protein affects the metabolism of aflatoxin B1-2,3-oxide | affects metabolic processing | 1638515 |
| D000477 | Alkylating Agents | GSTP1 mRNA results in increased susceptibility to Alkylating Agents | increases response to substance | 8700107 |
| D000477 | Alkylating Agents | GSTP1 protein results in increased susceptibility to Alkylating Agents | increases response to substance | 8700107 |
| C004471 | allyl isothiocyanate | GSTP1 protein affects the metabolism of allyl isothiocyanate | affects metabolic processing | 7826396 |
| C040534 | alpha-hexachlorocyclohexane | alpha-hexachlorocyclohexane results in increased expression of GSTP1 mRNA | increases expression | 16940010 |
| C040534 | alpha-hexachlorocyclohexane | [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in decreased expression of GSTP1 protein | affects cotreatment|decreases expression | 16246485 |
| C040534 | alpha-hexachlorocyclohexane | [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 16246485 |
| C011512 | alpha-naphthoflavone | [beta-Naphthoflavone co-treated with alpha-naphthoflavone] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 19233942 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased expression of GSTP1 mRNA | decreases expression | 18762178 |
| D000639 | Amitriptyline | Amitriptyline results in decreased activity of GSTP1 protein | decreases activity | 15094841 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of GSTP1 mRNA | affects expression | 16483693 |
| C019257 | angelica lactone | angelica lactone results in increased expression of GSTP1 protein | increases expression | 11309284 |
| C526219 | apple polyphenol extract | apple polyphenol extract results in increased expression of GSTP1 mRNA | increases expression | 16369997 |
| C030610 | argemone oil | argemone oil results in increased expression of GSTP1 protein | increases expression | 15981203 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of GSTP1 mRNA | increases expression | 17961207 |
| C006632 | arsenic trioxide | GSTP1 protein results in decreased susceptibility to arsenic trioxide | decreases response to substance | 15231573 |
| C015001 | arsenite | GSTP1 protein results in increased transport of arsenite | increases transport | 15161912 |
| C015001 | arsenite | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 15894712 |
| C015001 | arsenite | arsenite results in increased expression of GSTP1 mRNA | increases expression | 15894712 15345372 |
| C031327 | artemisinine | artemisinine results in decreased activity of GSTP1 protein | decreases activity | 11807801 |
| D001194 | Asbestos | GSTP1 gene polymorphism affects the susceptibility to Asbestos | affects response to substance | 17159790 |
| D001280 | Atrazine | GSTP1 protein affects the metabolism of [Atrazine co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 15115887 |
| D001280 | Atrazine | GSTP1 protein affects the metabolism of [Atrazine co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 15115887 |
| D001280 | Atrazine | GSTP1 protein results in increased metabolism of Atrazine | increases metabolic processing | 7873571 |
| D001554 | Benzene | GSTP1 gene polymorphism affects the susceptibility to Benzene | affects response to substance | 15591089 |
| D001554 | Benzene | GSTP1 protein affects the metabolism of Benzene | affects metabolic processing | 15226677 |
| D001554 | Benzene | GSTP1 protein results in increased metabolism of Benzene | increases metabolic processing | 17885617 |
| C110144 | benzo(c)chrysene | GSTP1 protein affects the metabolism of [benzo(c)chrysene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173 |
| C002615 | benzo(c)phenanthrene | GSTP1 gene polymorphism affects the metabolism of benzo(c)phenanthrene analog | affects metabolic processing | 9850062 |
| C002615 | benzo(c)phenanthrene | GSTP1 protein affects the metabolism of [benzo(c)phenanthrene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173 |
| D019324 | beta-Naphthoflavone | [beta-Naphthoflavone co-treated with alpha-naphthoflavone] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 19233942 |
| C100422 | benzo(g)chrysene | GSTP1 gene polymorphism affects the metabolism of benzo(g)chrysene analog | affects metabolic processing | 9850062 |
| C100422 | benzo(g)chrysene | GSTP1 protein affects the metabolism of [benzo(g)chrysene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of GSTP1 mRNA | increases expression | 20498004 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of GSTP1 protein | increases expression | 20498004 |
| D001564 | Benzo(a)pyrene | Buthionine Sulfoximine inhibits the reaction [GSTP1 results in decreased susceptibility to Benzo(a)pyrene] | decreases reaction|decreases response to substance | 19330882 |
| D001564 | Benzo(a)pyrene | GSTP1 protein polymorphism affects the metabolism of and affects the activity of Benzo(a)pyrene | affects activity|affects metabolic processing | 15298956 |
| D001564 | Benzo(a)pyrene | GSTP1 protein results in decreased susceptibility to Benzo(a)pyrene | decreases response to substance | 2747627 |
| D001564 | Benzo(a)pyrene | GSTP1 protein results in decreased susceptibility to Benzo(a)pyrene metabolite | decreases response to substance | 2747627 |
| D001564 | Benzo(a)pyrene | GSTP1 results in decreased susceptibility to Benzo(a)pyrene | decreases response to substance | 19330882 |
| D001564 | Benzo(a)pyrene | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 15894712 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of GSTP1 mRNA | increases expression | 15894712 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of GSTP1 protein | increases expression | 9395218 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of GSTP1 mRNA | increases expression | 20382262 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | GSTP1 protein affects the metabolism of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | GSTP1 protein affects the metabolism of and results in decreased activity of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing|decreases activity | 11849043 |
| C031403 | benzyl isothiocyanate | benzyl isothiocyanate binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 15355982 |
| C031403 | benzyl isothiocyanate | GSTP1 protein affects the metabolism of benzyl isothiocyanate | affects metabolic processing | 15355982 7826396 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GSTP1 protein | increases expression | 15863507 |
| C014638 | beta-lapachone | beta-lapachone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| C014638 | beta-lapachone | beta-lapachone inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| C477843 | bicyclol | bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 17106253 |
| C477843 | bicyclol | bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein] | decreases reaction|increases expression | 17106253 |
| C032036 | bromobenzene | bromobenzene results in increased expression of GSTP1 protein | increases expression | 10547960 |
| D002066 | Busulfan | GSTP1 protein affects the metabolism of Busulfan | affects metabolic processing | 8886613 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [GSTP1 results in decreased susceptibility to Benzo(a)pyrene] | decreases reaction|decreases response to substance | 19330882 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased expression of GSTP1 protein | increases expression | 2597111 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased expression of GSTP1 mRNA | increases expression | 15110098 |
| D020122 | tert-Butylhydroperoxide | NFE2L2 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA] | affects reaction|increases expression | 19233942 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA | increases expression | 19233942 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA | increases expression | 15336504 |
| D002087 | Butyrates | Butyrates results in increased expression of GSTP1 mRNA | increases expression | 15746163 |
| D002087 | Butyrates | Butyrates results in increased expression of GSTP1 protein | increases expression | 12896903 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of GSTP1 mRNA | increases expression | 17481689 |
| D019256 | Cadmium Chloride | [Cadmium Chloride co-treated with zinc chloride] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 15602745 |
| C040048 | caffeic acid | caffeic acid results in decreased activity of GSTP1 protein | decreases activity | 8340025 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in decreased expression of GSTP1 protein | decreases expression | 17106925 |
| D002166 | Camptothecin | Camptothecin results in increased expression of GSTP1 protein | increases expression | 15500952 |
| D002166 | Camptothecin | GSTP1 protein polymorphism results in decreased susceptibility to Camptothecin | decreases response to substance | 15500952 |
| D002166 | Camptothecin | GSTP1 protein results in decreased susceptibility to Camptothecin | decreases response to substance | 15500952 14732228 |
| D002211 | Capsaicin | Capsaicin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| D002211 | Capsaicin | Capsaicin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| C001614 | captafol | captafol results in decreased activity of GSTP1 protein | decreases activity | 8678907 |
| C001614 | captafol | hexylglutathione inhibits the reaction [captafol results in decreased activity of GSTP1 protein] | decreases activity|decreases reaction | 8678907 |
| D002215 | Captan | Captan results in decreased activity of GSTP1 protein | decreases activity | 8678907 |
| D002215 | Captan | hexylglutathione inhibits the reaction [Captan results in decreased activity of GSTP1 protein] | decreases activity|decreases reaction | 8678907 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of GSTP1 mRNA | affects expression | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of GSTP1 mRNA | increases expression | 15963578 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of GSTP1 mRNA | affects expression | 12734012 |
| D002251 | Carbon Tetrachloride | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein | affects cotreatment|decreases activity | 12725062 |
| D002251 | Carbon Tetrachloride | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 12725062 |
| D002251 | Carbon Tetrachloride | Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein] | affects cotreatment|decreases activity|decreases reaction | 12725062 |
| D002251 | Carbon Tetrachloride | Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein] | affects cotreatment|decreases reaction|increases expression | 12725062 |
| D002330 | Carmustine | GSTP1 protein results in decreased susceptibility to Carmustine | decreases response to substance | 16899598 |
| C105934 | celecoxib | celecoxib results in increased expression of GSTP1 mRNA | increases expression | 18089846 |
| C105934 | celecoxib | PTGS2 protein affects the reaction [celecoxib results in increased expression of GSTP1 mRNA] | affects reaction|increases expression | 18089846 |
| D002699 | Chlorambucil | Chlorambucil binds to GSTP1 protein | affects binding | 18511072 |
| D002699 | Chlorambucil | GSTP1 gene affects the susceptibility to Chlorambucil | affects response to substance | 11071881 |
| D002699 | Chlorambucil | GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Chlorambucil] | decreases response to substance|increases reaction | 10900222 |
| D002699 | Chlorambucil | GSTP1 protein results in decreased susceptibility to Chlorambucil | decreases response to substance | 10900222 |
| D002699 | Chlorambucil | GSTP1 protein results in increased metabolism of Chlorambucil | increases metabolic processing | 11071881 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of GSTP1 mRNA | increases expression | 16945589 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 9463521 |
| C098869 | clasto-lactacystin beta-lactone | clasto-lactacystin beta-lactone results in increased expression of GSTP1 protein | increases expression | 15863507 |
| D002997 | Clomipramine | Clomipramine results in decreased activity of GSTP1 protein | decreases activity | 15094841 |
| D003033 | Coal Tar | Coal Tar results in increased expression of GSTP1 mRNA | increases expression | 16882163 |
| C515714 | copper (N-2-hydroxyacetophenone)glycinate | copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTP1 protein | decreases expression | 16289015 |
| C515714 | copper (N-2-hydroxyacetophenone)glycinate | [copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTP1 protein] which results in increased susceptibility to Doxorubicin | decreases expression|increases response to substance | 16289015 |
| C030123 | coumarin | coumarin results in increased expression of GSTP1 protein | increases expression | 11309284 |
| C015763 | cumene | cumene affects the localization of GSTP1 protein | affects localization | 18409811 |
| C015763 | cumene | cumene results in decreased activity of GSTP1 protein | decreases activity | 18409811 |
| C007164 | cumene hydroperoxide | GSTP1 protein results in increased metabolism of cumene hydroperoxide | increases metabolic processing | 2747627 |
| C007164 | cumene hydroperoxide | GSTP1 protein affects the metabolism of cumene hydroperoxide | affects metabolic processing | 11684093 |
| D003474 | Curcumin | Curcumin binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 9463521 |
| D003474 | Curcumin | Curcumin inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 15999103 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 14555224 |
| D003474 | Curcumin | Curcumin promotes the reaction [NFE2L2 protein binds to GSTP1 promoter] | affects binding|increases reaction | 17449203 |
| D003474 | Curcumin | Curcumin promotes the reaction [NFE2L2 protein results in increased expression of GSTP1 mRNA] | increases expression|increases reaction | 17449203 |
| D003474 | Curcumin | Curcumin results in decreased expression of GSTP1 mRNA | decreases expression | 14555224 18414057 |
| D003474 | Curcumin | Curcumin results in decreased expression of GSTP1 protein | decreases expression | 14555224 |
| D003474 | Curcumin | Curcumin results in increased expression of GSTP1 mRNA | increases expression | 16101141 17449203 |
| D003474 | Curcumin | Curcumin results in increased expression of GSTP1 protein | increases expression | 14742295 |
| D003474 | Curcumin | [sulfinosine co-treated with Curcumin] results in decreased expression of GSTP1 mRNA | affects cotreatment|decreases expression | 18414057 |
| D003474 | Curcumin | Curcumin results in increased expression of GSTP1 mRNA | increases expression | 18299980 |
| D003511 | Cyclohexanols | [Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 17393424 |
| D003520 | Cyclophosphamide | GSTP1 protein results in decreased susceptibility to Cyclophosphamide | decreases response to substance | 10954901 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of GSTP1 mRNA | increases expression | 16242832 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of GSTP1 protein | increases expression | 16242832 |
| D003545 | Cysteine | Cysteine affects the expression of GSTP1 protein | affects expression | 15203113 |
| D018119 | Stavudine | Stavudine results in increased expression of GSTP1 mRNA | increases expression | 18299183 |
| D003609 | Dactinomycin | GSTP1 protein results in decreased susceptibility to Dactinomycin | decreases response to substance | 11455017 |
| C014347 | decitabine | [decitabine co-treated with trichostatin A] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 17891453 |
| C014347 | decitabine | decitabine results in decreased methylation of GSTP1 promoter | decreases methylation | 18174752 18676679 |
| C014347 | decitabine | decitabine results in increased expression of GSTP1 mRNA | increases expression | 18174752 18676679 |
| C014347 | decitabine | decitabine results in increased expression of GSTP1 protein | increases expression | 18676679 19396019 |
| C014347 | decitabine | PD 98059 inhibits the reaction [decitabine results in increased expression of GSTP1 protein] | decreases reaction|increases expression | 19396019 |
| C014347 | decitabine | [decitabine co-treated with trichostatin A] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 19444856 |
| D003840 | Deoxycholic Acid | Deoxycholic Acid binds to GSTP1 protein | affects binding | 15300575 |
| D003840 | Deoxycholic Acid | gamma-Glu-S-BzCys-PhGly diethyl ester inhibits the reaction [GSTP1 protein results in increased susceptibility to Deoxycholic Acid] | decreases reaction|increases response to substance | 15300575 |
| D003840 | Deoxycholic Acid | GSTP1 protein results in increased susceptibility to Deoxycholic Acid | increases response to substance | 15300575 |
| D016190 | Carboplatin | GSTP1 gene affects the susceptibility to Carboplatin | affects response to substance | 12360105 |
| C041517 | dibenzo(a,l)pyrene | GSTP1 protein affects the metabolism of and results in decreased activity of [dibenzo(a,l)pyrene co-treated with Glutathione] | affects cotreatment|affects metabolic processing|decreases activity | 11849043 |
| C041517 | dibenzo(a,l)pyrene | GSTP1 results in decreased susceptibility to dibenzo(a,l)pyrene | decreases response to substance | 19330882 |
| D002945 | Cisplatin | [Cisplatin co-treated with Fluorouracil] results in decreased expression of GSTP1 mRNA | affects cotreatment|decreases expression | 15737843 |
| D002945 | Cisplatin | GSTP1 gene affects the susceptibility to Cisplatin | affects response to substance | 12360105 |
| D002945 | Cisplatin | GSTP1 gene polymorphism affects the susceptibility to Cisplatin | affects response to substance | 16785472 |
| D002945 | Cisplatin | GSTP1 gene polymorphism results in decreased susceptibility to [Fluorouracil co-treated with Cisplatin] | affects cotreatment|decreases response to substance | 16622263 |
| D002945 | Cisplatin | GSTP1 mRNA results in increased susceptibility to Cisplatin | increases response to substance | 15239142 |
| D002945 | Cisplatin | GSTP1 protein results in decreased susceptibility to Cisplatin | decreases response to substance | 15279901 19396019 |
| D002945 | Cisplatin | GSTP1 results in decreased susceptibility to Cisplatin | decreases response to substance | 14678959 |
| D002945 | Cisplatin | GSTP1 protein results in decreased susceptibility to Cisplatin | decreases response to substance | 12964789 |
| D002945 | Cisplatin | GSTP1 protein results in decreased susceptibility to Cisplatin | decreases response to substance | 11455017 |
| D004052 | Diethylnitrosamine | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 18271918 |
| D004052 | Diethylnitrosamine | 2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein] | increases expression|increases reaction | 19052882 |
| D004052 | Diethylnitrosamine | bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 17106253 |
| D004052 | Diethylnitrosamine | bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein] | decreases reaction|increases expression | 17106253 |
| D004052 | Diethylnitrosamine | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein | affects cotreatment|decreases activity | 12725062 |
| D004052 | Diethylnitrosamine | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 12725062 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 12781041 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 12781041 17393424 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in decreased expression of GSTP1 protein | affects cotreatment|decreases expression | 16246485 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 16246485 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 17393424 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 18648771 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of GSTP1 mRNA | increases expression | 17106253 19638242 3124819 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of GSTP1 protein | increases expression | 19052882 17106253 |
| D004052 | Diethylnitrosamine | herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA] | affects cotreatment|decreases reaction|increases expression | 12907702 |
| D004052 | Diethylnitrosamine | herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein] | affects cotreatment|decreases reaction|increases expression | 12907702 |
| D004052 | Diethylnitrosamine | [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 20935162 |
| D004052 | Diethylnitrosamine | Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein] | affects cotreatment|decreases activity|decreases reaction | 12725062 |
| D004052 | Diethylnitrosamine | Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein] | affects cotreatment|decreases reaction|increases expression | 12725062 |
| D015102 | 3,4-Dihydroxyphenylacetic Acid | 3,4-Dihydroxyphenylacetic Acid results in increased expression of GSTP1 mRNA | increases expression | 19743802 |
| D004126 | Dimethylformamide | Dimethylformamide results in increased expression of GSTP1 protein | increases expression | 10547960 |
| D004137 | Dinitrochlorobenzene | GSTP1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 14508638 |
| D004137 | Dinitrochlorobenzene | GSTP1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 10870112 15355982 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in decreased activity of GSTP1 protein | decreases activity | 9794801 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of GSTP1 protein | increases expression | 9794801 |
| D004137 | Dinitrochlorobenzene | GSTP1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 2619714 |
| D004137 | Dinitrochlorobenzene | GSTP1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 14573868 |
| C067311 | docetaxel | GSTP1 mRNA results in increased susceptibility to docetaxel | increases response to substance | 15239142 |
| D004298 | Dopamine | Dopamine analog results in decreased activity of GSTP1 protein | decreases activity | 8131222 |
| D004316 | Doxepin | Doxepin results in decreased activity of GSTP1 protein | decreases activity | 15094841 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [GATA1 protein binds to GSTP1 promoter] | affects binding|increases reaction | 14623254 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of GSTP1 mRNA | increases expression | 16579640 15205334 15533597 14623254 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of GSTP1 protein | increases expression | 14623254 |
| D004317 | Doxorubicin | [GCLC protein co-treated with GCLM protein] promotes the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin] | affects cotreatment|decreases response to substance|increases reaction | 10900222 |
| D004317 | Doxorubicin | GSTP1 mRNA results in decreased susceptibility to Doxorubicin | decreases response to substance | 15448748 |
| D004317 | Doxorubicin | GSTP1 promoter modified form results in decreased susceptibility to Doxorubicin | decreases response to substance | 16356834 |
| D004317 | Doxorubicin | GSTP1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747 18225754 |
| D004317 | Doxorubicin | Haloperidol inhibits the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 15946544 |
| D004317 | Doxorubicin | [copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTP1 protein] which results in increased susceptibility to Doxorubicin | decreases expression|increases response to substance | 16289015 |
| D004317 | Doxorubicin | GSTP1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 16289015 |
| D004317 | Doxorubicin | GSTP1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 12964789 |
| D004317 | Doxorubicin | GSTP1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 11455017 |
| C042986 | ebselen | ebselen binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 8147899 |
| D004642 | Emodin | Emodin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| D004642 | Emodin | Emodin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased expression of GSTP1 mRNA | decreases expression | 18851785 |
| C007619 | eriodictyol | eriodictyol results in decreased activity of GSTP1 protein | decreases activity | 15041478 |
| D004976 | Ethacrynic Acid | Ethacrynic Acid analog results in decreased activity of GSTP1 protein | decreases activity | 15911318 |
| D004976 | Ethacrynic Acid | Ethacrynic Acid binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 9463521 |
| D004976 | Ethacrynic Acid | Ethacrynic Acid inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin] | affects metabolic processing|decreases reaction | 9806904 |
| D004976 | Ethacrynic Acid | Ethacrynic Acid inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 15999103 |
| D004976 | Ethacrynic Acid | Ethacrynic Acid results in decreased activity of GSTP1 protein | decreases activity | 15911318 |
| D004976 | Ethacrynic Acid | Ethacrynic Acid results in increased expression of GSTP1 protein | increases expression | 14556662 |
| D004976 | Ethacrynic Acid | GSTP1 protein affects the metabolism of Ethacrynic Acid analog | affects metabolic processing | 12781783 |
| D004976 | Ethacrynic Acid | GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Ethacrynic Acid] | decreases response to substance|increases reaction | 10900222 |
| D004976 | Ethacrynic Acid | GSTP1 protein results in decreased susceptibility to Ethacrynic Acid | decreases response to substance | 2747627 10900222 |
| D004976 | Ethacrynic Acid | Pyrimethamine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] | affects metabolic processing|decreases activity|decreases reaction | 11807801 |
| D004976 | Ethacrynic Acid | Quinidine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] | affects metabolic processing|decreases activity|decreases reaction | 11807801 |
| D004976 | Ethacrynic Acid | Quinine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] | affects metabolic processing|decreases activity|decreases reaction | 11807801 |
| D004976 | Ethacrynic Acid | Tetracycline inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] | affects metabolic processing|decreases activity|decreases reaction | 11807801 |
| D004976 | Ethacrynic Acid | GSTP1 protein affects the metabolism of Ethacrynic Acid | affects metabolic processing | 9877184 2619714 |
| D004976 | Ethacrynic Acid | Ethacrynic Acid results in decreased activity of GSTP1 protein | decreases activity | 11455017 |
| D000431 | Ethanol | Ethanol results in increased expression of GSTP1 protein | increases expression | 18271918 |
| D005015 | Ethoxyquin | Ethoxyquin results in increased expression of GSTP1 protein | increases expression | 8198522 |
| C004912 | ethylbenzene | ethylbenzene results in decreased activity of GSTP1 protein | decreases activity | 18409811 |
| D005031 | Ethylenethiourea | Ethylenethiourea results in increased expression of GSTP1 mRNA | increases expression | 18801409 |
| D005047 | Etoposide | Curcumin inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 15999103 |
| D005047 | Etoposide | Ethacrynic Acid inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 15999103 |
| D005047 | Etoposide | GSTP1 gene polymorphism affects the susceptibility to Etoposide | affects response to substance | 12969965 |
| D005047 | Etoposide | GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases response to substance|increases reaction | 10900222 |
| D005047 | Etoposide | GSTP1 protein results in decreased susceptibility to Etoposide | decreases response to substance | 10900222 15999103 |
| D005047 | Etoposide | Sulfinpyrazone inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 15999103 |
| D005047 | Etoposide | verlukast inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 15999103 |
| D005054 | Eugenol | Eugenol analog results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| D005054 | Eugenol | Eugenol analog results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| D015525 | Fatty Acids, Omega-3 | GSTP1 gene polymorphism affects the susceptibility to Fatty Acids, Omega-3 | affects response to substance | 15256483 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of GSTP1 mRNA | decreases expression | 15465739 |
| D015073 | 2-Acetylaminofluorene | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 18271918 |
| D015073 | 2-Acetylaminofluorene | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 12781041 |
| D015073 | 2-Acetylaminofluorene | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 17393424 12781041 |
| D015073 | 2-Acetylaminofluorene | herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA] | affects cotreatment|decreases reaction|increases expression | 12907702 |
| D015073 | 2-Acetylaminofluorene | herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein] | affects cotreatment|decreases reaction|increases expression | 12907702 |
| D005472 | Fluorouracil | [Cisplatin co-treated with Fluorouracil] results in decreased expression of GSTP1 mRNA | affects cotreatment|decreases expression | 15737843 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of GSTP1 mRNA | increases expression | 15205334 |
| D005472 | Fluorouracil | GSTP1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with oxaliplatin] | affects cotreatment|affects response to substance | 15213713 |
| D005472 | Fluorouracil | GSTP1 gene polymorphism results in decreased susceptibility to [Fluorouracil co-treated with Cisplatin] | affects cotreatment|decreases response to substance | 16622263 |
| C037032 | galangin | galangin results in decreased activity of GSTP1 protein | decreases activity | 15041478 |
| C096329 | gamma-Glu-S-BzCys-PhGly diethyl ester | gamma-Glu-S-BzCys-PhGly diethyl ester inhibits the reaction [GSTP1 protein results in increased susceptibility to Deoxycholic Acid] | decreases reaction|increases response to substance | 15300575 |
| C050159 | gamma-glutamyl-glutathione | GSTP1 protein binds to and affects the metabolism of gamma-glutamyl-glutathione | affects binding|affects metabolic processing | 2619714 |
| D005978 | Glutathione | Glutathione analog results in decreased activity of GSTP1 protein | decreases activity | 13679171 |
| D005978 | Glutathione | GSTP1 gene affects the reaction [Glutathione affects the metabolism of Thiotepa] | affects metabolic processing|affects reaction | 10334868 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [4-oxo-2-nonenal co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 15528046 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [6-bromoacetyl-2-dimethylaminonaphthalene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 12470677 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [acrylodan co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 12470677 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of and results in decreased activity of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing|decreases activity | 11849043 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of and results in decreased activity of [dibenzo(a,l)pyrene co-treated with Glutathione] | affects cotreatment|affects metabolic processing|decreases activity | 11849043 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [Atrazine co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 15115887 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [benzo(c)chrysene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [benzo(c)phenanthrene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [benzo(g)chrysene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of Glutathione | affects metabolic processing | 7826396 8886613 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [hydratropic aldehyde co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 11368548 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [Thiotepa co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 7712478 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [Atrazine co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 15115887 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 8973562 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of Glutathione | affects metabolic processing | 9877184 |
| D005978 | Glutathione | GSTP1 protein affects the metabolism of [monobromobimane co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 14573868 |
| C004333 | goitrin | goitrin results in decreased expression of GSTP1 protein | decreases expression | 7532609 |
| C004333 | goitrin | goitrin results in increased expression of GSTP1 protein | increases expression | 7532609 |
| C004333 | goitrin | Triiodothyronine inhibits the reaction [goitrin results in increased expression of GSTP1 protein] | decreases reaction|increases expression | 7532609 |
| D006220 | Haloperidol | Haloperidol inhibits the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 15946544 |
| D006220 | Haloperidol | Haloperidol results in decreased expression of GSTP1 mRNA | decreases expression | 15946544 |
| D006427 | Hemin | Hemin results in increased stability of and results in increased expression of GSTP1 mRNA | increases expression|increases stability | 15313425 |
| C476499 | herbal compound 861 | herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA] | affects cotreatment|decreases reaction|increases expression | 12907702 |
| C476499 | herbal compound 861 | herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein] | affects cotreatment|decreases reaction|increases expression | 12907702 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of GSTP1 protein | increases expression | 9630449 10696772 |
| C033550 | hexylglutathione | hexylglutathione inhibits the reaction [captafol results in decreased activity of GSTP1 protein] | decreases activity|decreases reaction | 8678907 |
| C033550 | hexylglutathione | hexylglutathione inhibits the reaction [Captan results in decreased activity of GSTP1 protein] | decreases activity|decreases reaction | 8678907 |
| D006830 | Hydralazine | Hydralazine results in decreased methylation of GSTP1 promoter | decreases methylation | 15862127 |
| D006830 | Hydralazine | Hydralazine results in increased expression of GSTP1 mRNA | increases expression | 15862127 |
| C013026 | hydratropic aldehyde | GSTP1 protein affects the metabolism of [hydratropic aldehyde co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 11368548 |
| C013026 | hydratropic aldehyde | GSTP1 protein results in decreased activity of hydratropic aldehyde | decreases activity | 11368548 |
| C013026 | hydratropic aldehyde | hydratropic aldehyde results in decreased activity of GSTP1 protein | decreases activity | 11368548 |
| D006841 | Hydrocarbons, Aromatic | GSTP1 protein affects the metabolism of Hydrocarbons, Aromatic | affects metabolic processing | 12359356 |
| D006861 | Hydrogen Peroxide | GSTP1 protein results in decreased susceptibility to Hydrogen Peroxide | decreases response to substance | 15528046 |
| D006861 | Hydrogen Peroxide | GSTP1 protein results in increased degradation of and results in decreased susceptibility to Hydrogen Peroxide | decreases response to substance|increases degradation | 15231573 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the localization of GSTP1 protein | affects localization | 15528046 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of GSTP1 mRNA | decreases expression | 12419474 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of GSTP1 protein | decreases expression | 15832819 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of GSTP1 mRNA | increases expression | 15533597 15056853 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of GSTP1 protein | increases expression | 15056853 |
| D006861 | Hydrogen Peroxide | GSTP1 protein results in decreased susceptibility to Hydrogen Peroxide | decreases response to substance | 15386426 |
| C012353 | hydroperoxyisophosphamide | GSTP1 gene affects the susceptibility to hydroperoxyisophosphamide | affects response to substance | 12360105 |
| C004965 | hypericin | hypericin binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 15461448 |
| D007069 | Ifosfamide | GSTP1 gene polymorphism affects the susceptibility to Ifosfamide | affects response to substance | 12868187 |
| D007099 | Imipramine | Imipramine results in decreased activity of GSTP1 protein | decreases activity | 15094841 |
| C027185 | indirubin | indirubin results in increased expression of GSTP1 mRNA | increases expression | 15056799 |
| C031050 | isomethyleugenol | isomethyleugenol results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| C031050 | isomethyleugenol | isomethyleugenol results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| C015304 | isopimpinellin | isopimpinellin results in increased expression of GSTP1 mRNA | increases expression | 18692084 |
| D017879 | Isothiocyanates | GSTP1 gene SNP affects the susceptibility to Isothiocyanates | affects response to substance | 14693750 |
| C006552 | kaempferol | kaempferol results in decreased activity of GSTP1 protein | decreases activity | 15041478 |
| C008261 | lead acetate | lead acetate affects the localization of GSTP1 protein | affects localization | 9750042 |
| C008261 | lead acetate | lead acetate results in increased expression of GSTP1 mRNA | increases expression | 9750042 |
| C008261 | lead acetate | lead acetate results in increased expression of GSTP1 protein | increases expression | 9750042 7878682 |
| C029891 | lead chloride | lead chloride results in increased expression of GSTP1 mRNA | increases expression | 17961207 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] | decreases reaction|increases degradation | 16023107 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] | decreases reaction|increases expression | 16023107 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] | decreases reaction|increases phosphorylation | 16023107 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16023107 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 16023107 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] | decreases reaction|increases phosphorylation | 16023107 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | decreases reaction|increases phosphorylation | 16023107 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] | decreases reaction|increases secretion | 16023107 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of GSTP1 mRNA | increases expression | 16023107 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of GSTP1 protein | increases expression | 16023107 |
| D008694 | Methamphetamine | GSTP1 exon polymorphism results in increased susceptibility to Methamphetamine | increases response to substance | 15729709 |
| D008750 | Methyldopa | Methyldopa analog results in decreased activity of GSTP1 protein | decreases activity | 8131222 |
| C005223 | methyleugenol | methyleugenol results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| C005223 | methyleugenol | methyleugenol results in decreased activity of GSTP1 protein | decreases activity | 8620581 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of GSTP1 mRNA | increases expression | 17961207 |
| D016685 | Mitomycin | GSTP1 mRNA results in increased susceptibility to Mitomycin | increases response to substance | 15239142 |
| D016685 | Mitomycin | GSTP1 protein results in decreased susceptibility to Mitomycin | decreases response to substance | 12964789 |
| C028381 | monobromobimane | GSTP1 protein affects the metabolism of monobromobimane | affects metabolic processing | 15355982 |
| C028381 | monobromobimane | GSTP1 protein affects the metabolism of [monobromobimane co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 14573868 |
| C028381 | monobromobimane | monobromobimane results in decreased activity of GSTP1 protein | decreases activity | 14573868 |
| C020300 | monomethylarsonic acid | monomethylarsonic acid results in increased expression of GSTP1 mRNA | increases expression | 17481689 |
| C031721 | naphthalene | naphthalene metabolite binds to GSTP1 protein | affects binding | 16453347 |
| C031721 | naphthalene | naphthalene results in increased expression of GSTP1 protein | increases expression | 10959795 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of GSTP1 mRNA | increases expression | 15913567 |
| D009498 | Neurotoxins | GSTP1 protein polymorphism affects the susceptibility to Neurotoxins | affects response to substance | 9802272 |
| C012103 | N,N-dimethyl-4-(6-benzothiazolylazo)aniline | N,N-dimethyl-4-(6-benzothiazolylazo)aniline results in increased expression of GSTP1 mRNA | increases expression | 3124819 |
| C025256 | nonylphenol | nonylphenol results in increased expression of GSTP1 mRNA | increases expression | 19167021 |
| C510003 | nordy | nordy results in increased expression of GSTP1 protein | increases expression | 18232056 |
| C026209 | oltipraz | oltipraz results in increased expression of and results in increased activity of GSTP1 protein | increases activity|increases expression | 16950796 |
| C026209 | oltipraz | oltipraz results in increased expression of GSTP1 mRNA | increases expression | 15374950 |
| C030110 | oxaliplatin | GSTP1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with oxaliplatin] | affects cotreatment|affects response to substance | 15213713 |
| C030110 | oxaliplatin | GSTP1 gene SNP affects the susceptibility to oxaliplatin | affects response to substance | 17401013 |
| C030110 | oxaliplatin | GSTP1 protein results in decreased activity of oxaliplatin | decreases activity | 15655543 |
| C030110 | oxaliplatin | GSTP1 protein results in decreased susceptibility to oxaliplatin | decreases response to substance | 15655543 |
| D010126 | Ozone | GSTP1 gene SNP affects the reaction [MS4A2 gene SNP affects the susceptibility to Ozone] | affects reaction|affects response to substance | 18269668 |
| D010126 | Ozone | GSTP1 gene SNP affects the reaction [TNF gene SNP affects the susceptibility to Ozone] | affects reaction|affects response to substance | 16456144 |
| D010126 | Ozone | GSTP1 gene SNP promotes the reaction [HMOX1 gene SNP results in increased susceptibility to Ozone] | increases reaction|increases response to substance | 18524839 |
| D010126 | Ozone | GSTP1 gene SNP results in increased susceptibility to Ozone | increases response to substance | 17652311 16870661 18524839 |
| D017239 | Paclitaxel | GSTP1 mRNA results in increased susceptibility to Paclitaxel | increases response to substance | 15239142 |
| D017239 | Paclitaxel | GSTP1 protein affects the susceptibility to Paclitaxel | affects response to substance | 16217747 |
| D010269 | Paraquat | Paraquat results in increased expression of GSTP1 mRNA | increases expression | 16128001 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [decitabine results in increased expression of GSTP1 protein] | decreases reaction|increases expression | 19396019 |
| C093973 | PD 98059 | PD 98059 results in decreased expression of GSTP1 protein | decreases expression | 19396019 |
| C003060 | pentachlorobenzene | pentachlorobenzene results in increased expression of GSTP1 protein | increases expression | 9630449 10696772 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of GSTP1 mRNA | increases expression | 18467677 |
| C023036 | perfluorooctanoic acid | PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of GSTP1 mRNA] | increases expression|increases reaction | 18467677 |
| D010575 | Pesticides | GSTP1 protein polymorphism affects the susceptibility to Pesticides | affects response to substance | 9802272 |
| C058305 | phenethyl isothiocyanate | GSTP1 protein affects the metabolism of phenethyl isothiocyanate | affects metabolic processing | 7826396 |
| D010634 | Phenobarbital | [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 20935162 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of GSTP1 mRNA | increases expression | 2563599 |
| D010882 | Piperonyl Butoxide | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 18648771 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of GSTP1 mRNA | decreases expression | 18467677 15375163 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of GSTP1 protein | decreases expression | 15226431 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GSTP1 mRNA] | decreases expression|increases reaction | 18467677 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of GSTP1 mRNA | decreases expression | 15465739 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of GSTP1 mRNA | decreases expression | 19650632 |
| D010984 | Platinum | [Acridine Orange binds to Platinum] which results in increased expression of GSTP1 mRNA | affects binding|increases expression | 16814760 |
| D010984 | Platinum | GSTP1 protein affects the susceptibility to Platinum | affects response to substance | 15788669 |
| D017671 | Platinum Compounds | [Acridine Orange binds to Platinum Compounds] which results in increased expression of GSTP1 mRNA | affects binding|increases expression | 16814760 |
| C095911 | polycyclic aromatic hydrocarbons-DNA adduct | GSTP1 protein polymorphism results in increased abundance of polycyclic aromatic hydrocarbons-DNA adduct | increases abundance | 11967624 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | GSTP1 gene affects the susceptibility to Polycyclic Hydrocarbons, Aromatic | affects response to substance | 15938845 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | GSTP1 gene polymorphism affects the susceptibility to Polycyclic Hydrocarbons, Aromatic | affects response to substance | 15466980 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | GSTP1 protein affects the metabolism of and results in decreased activity of Polycyclic Hydrocarbons, Aromatic | affects metabolic processing|decreases activity | 15122594 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | GSTP1 protein polymorphism results in increased metabolism of Polycyclic Hydrocarbons, Aromatic | increases metabolic processing | 15917149 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | GSTP1 protein polymorphism results in increased susceptibility to Polycyclic Hydrocarbons, Aromatic | increases response to substance | 11740339 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | GSTP1 protein results in decreased activity of Polycyclic Hydrocarbons, Aromatic | decreases activity | 15122594 |
| C025299 | polyphenols | polyphenols results in decreased expression of GSTP1 mRNA | decreases expression | 15465739 |
| C030984 | pyrene | pyrene results in increased expression of GSTP1 mRNA | increases expression | 15963578 |
| D011739 | Pyrimethamine | Pyrimethamine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] | affects metabolic processing|decreases activity|decreases reaction | 11807801 |
| D011739 | Pyrimethamine | Pyrimethamine results in decreased activity of GSTP1 protein | decreases activity | 11807801 |
| D011794 | Quercetin | Quercetin results in decreased activity of GSTP1 protein | decreases activity | 15041478 |
| D011794 | Quercetin | Quercetin affects the expression of GSTP1 mRNA | affects expression | 18178720 |
| D011794 | Quercetin | Quercetin results in increased expression of GSTP1 mRNA | increases expression | 19191009 |
| D011802 | Quinidine | Quinidine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] | affects metabolic processing|decreases activity|decreases reaction | 11807801 |
| D011802 | Quinidine | Quinidine results in decreased activity of GSTP1 protein | decreases activity | 11807801 |
| D011803 | Quinine | Quinine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] | affects metabolic processing|decreases activity|decreases reaction | 11807801 |
| D011803 | Quinine | Quinine results in decreased activity of GSTP1 protein | decreases activity | 11807801 |
| C059514 | resveratrol | resveratrol results in increased expression of GSTP1 mRNA | increases expression | 12002526 |
| D015474 | Isotretinoin | Ethacrynic Acid inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin] | affects metabolic processing|decreases reaction | 9806904 |
| D015474 | Isotretinoin | GSTP1 protein affects the metabolism of Isotretinoin | affects metabolic processing | 9806904 |
| D015474 | Isotretinoin | S-decylglutathione inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin] | affects metabolic processing|decreases reaction | 9806904 |
| C005705 | sanguinarine | sanguinarine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| C005705 | sanguinarine | sanguinarine inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| C005705 | sanguinarine | sanguinarine results in increased expression of GSTP1 protein | increases expression | 15981203 |
| C465222 | S-decylglutathione | S-decylglutathione inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin] | affects metabolic processing|decreases reaction | 9806904 |
| D012643 | Selenium | [Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA | affects cotreatment|decreases expression | 19244175 |
| D012643 | Selenium | Selenium results in increased expression of GSTP1 mRNA | increases expression | 19244175 |
| D012643 | Selenium | Selenium affects the expression of GSTP1 protein | affects expression | 7532609 |
| D018036 | Selenium Compounds | Selenium Compounds results in increased expression of GSTP1 mRNA | increases expression | 12034368 |
| D017279 | Selenocysteine | Selenocysteine results in increased expression of GSTP1 mRNA | increases expression | 12034368 |
| D012645 | Selenomethionine | Selenomethionine results in decreased methylation of GSTP1 promoter | decreases methylation | 18676679 |
| D012645 | Selenomethionine | Selenomethionine results in increased expression of GSTP1 mRNA | increases expression | 18676679 |
| D012645 | Selenomethionine | Selenomethionine results in increased expression of GSTP1 protein | increases expression | 18676679 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of GSTP1 mRNA | increases expression | 16882884 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GSTP1 mRNA | increases expression | 20339138 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of GSTP1 mRNA | affects expression | 16507464 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GSTP1 mRNA | increases expression | 17451858 14971641 |
| C017947 | sodium arsenite | GSTP1 protein results in decreased susceptibility to sodium arsenite | decreases response to substance | 11455017 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GSTP1 mRNA | increases expression | 12799770 11241755 16876216 11455017 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GSTP1 protein | increases expression | 11455017 |
| D018038 | Sodium Selenite | Sodium Selenite affects the reaction [HIST3H3 protein modified form binds to GSTP1 promoter] | affects binding|affects reaction | 18676679 |
| D018038 | Sodium Selenite | Sodium Selenite results in decreased methylation of GSTP1 promoter | decreases methylation | 18676679 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of GSTP1 mRNA | increases expression | 18676679 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of GSTP1 protein | increases expression | 18676679 |
| D013024 | Soybean Oil | Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 mRNA] | increases expression|increases reaction | 11600134 |
| D013024 | Soybean Oil | Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 protein] | increases expression|increases reaction | 11600134 |
| D020058 | Styrene | GSTP1 exon polymorphism affects the susceptibility to Styrene | affects response to substance | 12604177 |
| D020058 | Styrene | GSTP1 gene polymorphism affects the susceptibility to Styrene | affects response to substance | 12397415 |
| D020058 | Styrene | GSTP1 gene polymorphism promotes the reaction [Styrene results in increased mutagenesis of HPRT1 gene] | increases mutagenesis|increases reaction | 12893075 |
| D020058 | Styrene | GSTP1 gene polymorphism results in increased susceptibility to Styrene | increases response to substance | 11535253 |
| C013690 | styrene oxide | GSTP1 exon polymorphism affects the susceptibility to styrene oxide | affects response to substance | 12694745 |
| C063871 | sulfinosine | [sulfinosine co-treated with Curcumin] results in decreased expression of GSTP1 mRNA | affects cotreatment|decreases expression | 18414057 |
| D013442 | Sulfinpyrazone | Sulfinpyrazone inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 15999103 |
| C016766 | sulforafan | GSTP1 protein affects the metabolism of sulforafan | affects metabolic processing | 7826396 |
| C009359 | sulfotepp | sulfotepp results in decreased activity of GSTP1 protein | decreases activity | 18409811 |
| C025462 | sulindac sulfide | sulindac sulfide binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 15300575 |
| C025463 | sulindac sulfone | sulindac sulfone binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 15300575 |
| D014284 | Triiodothyronine | Triiodothyronine inhibits the reaction [goitrin results in increased expression of GSTP1 protein] | decreases reaction|increases expression | 7532609 |
| D013629 | Tamoxifen | GSTP1 protein polymorphism affects the susceptibility to Tamoxifen | affects response to substance | 15565566 |
| D013662 | Tea | Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein] | affects cotreatment|decreases activity|decreases reaction | 12725062 |
| D013662 | Tea | Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein] | affects cotreatment|decreases reaction|increases expression | 12725062 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A affects the expression of GSTP1 mRNA | affects expression | 18976794 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of GSTP1 mRNA | increases expression | 15716485 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of GSTP1 mRNA | increases expression | 15056799 19542225 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of GSTP1 mRNA | affects expression | 18343893 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of GSTP1 mRNA | decreases expression | 19465110 |
| D013752 | Tetracycline | Tetracycline inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] | affects metabolic processing|decreases activity|decreases reaction | 11807801 |
| D013752 | Tetracycline | Tetracycline results in decreased activity of GSTP1 protein | decreases activity | 11807801 |
| D013755 | Tetradecanoylphorbol Acetate | beta-lapachone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| D013755 | Tetradecanoylphorbol Acetate | Capsaicin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| D013755 | Tetradecanoylphorbol Acetate | Emodin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| D013755 | Tetradecanoylphorbol Acetate | sanguinarine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] | decreases reaction|increases expression | 15313406 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [GATA1 protein binds to GSTP1 promoter] | affects binding|increases reaction | 14623254 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of GSTP1 mRNA | decreases expression | 14623254 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of GSTP1 protein | decreases expression | 14623254 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA | increases expression | 15533597 15313406 |
| D013827 | Thiabendazole | Thiabendazole results in increased expression of GSTP1 mRNA | increases expression | 15110098 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of GSTP1 mRNA | increases expression | 10634158 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of GSTP1 protein | increases expression | 10634158 |
| D013876 | Thiophenes | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of GSTP1 mRNA] | increases expression|increases reaction | 16140955 |
| D013852 | Thiotepa | GSTP1 gene affects the reaction [Glutathione affects the metabolism of Thiotepa] | affects metabolic processing|affects reaction | 10334868 |
| D013852 | Thiotepa | GSTP1 gene affects the susceptibility to Thiotepa | affects response to substance | 10334868 12360105 |
| D013852 | Thiotepa | GSTP1 gene polymorphism affects the metabolism of Thiotepa | affects metabolic processing | 10334868 |
| D013852 | Thiotepa | GSTP1 gene polymorphism results in decreased susceptibility to Thiotepa | decreases response to substance | 10334868 |
| D013852 | Thiotepa | GSTP1 gene SNP affects the export of Thiotepa | affects export | 19076156 |
| D013852 | Thiotepa | GSTP1 protein affects the metabolism of [Thiotepa co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 7712478 |
| D013852 | Thiotepa | GSTP1 protein affects the susceptibility to Thiotepa | affects response to substance | 10334868 19076156 |
| D013852 | Thiotepa | GSTP1 protein results in increased metabolism of Thiotepa | increases metabolic processing | 10334868 |
| C411320 | thonningianin A | thonningianin A results in decreased activity of GSTP1 protein | decreases activity | 15234070 |
| D014050 | Toluene | GSTP1 gene polymorphism affects the susceptibility to Toluene | affects response to substance | 17292523 |
| D014050 | Toluene | Toluene affects the expression of GSTP1 mRNA | affects expression | 18653662 |
| D014051 | Toluene 2,4-Diisocyanate | GSTP1 gene polymorphism affects the metabolism of Toluene 2,4-Diisocyanate | affects metabolic processing | 20032816 |
| D014051 | Toluene 2,4-Diisocyanate | GSTP1 gene polymorphism affects the susceptibility to Toluene 2,4-Diisocyanate | affects response to substance | 20032816 |
| D014212 | Tretinoin | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of GSTP1 mRNA] | increases expression|increases reaction | 16140955 |
| D014212 | Tretinoin | Tretinoin results in increased expression of GSTP1 mRNA | increases expression | 16882163 16140955 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of GSTP1 protein | decreases expression | 1917145 |
| C012589 | trichostatin A | [decitabine co-treated with trichostatin A] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 17891453 |
| C012589 | trichostatin A | trichostatin A affects the expression of GSTP1 protein | affects expression | 19294695 |
| C012589 | trichostatin A | [decitabine co-treated with trichostatin A] results in increased expression of GSTP1 mRNA | affects cotreatment|increases expression | 19444856 |
| C020946 | triethylene glycol dimethacrylate | GSTP1 gene polymorphism results in increased susceptibility to triethylene glycol dimethacrylate | increases response to substance | 15557397 |
| C020946 | triethylene glycol dimethacrylate | triethylene glycol dimethacrylate binds to and results in decreased activity of GSTP1 protein | affects binding|decreases activity | 15557397 |
| C020946 | triethylene glycol dimethacrylate | triethylene glycol dimethacrylate results in increased activity of GSTP1 protein | increases activity | 15557397 |
| D013721 | Triethylenephosphoramide | GSTP1 gene SNP affects the export of Triethylenephosphoramide | affects export | 19076156 |
| D013721 | Triethylenephosphoramide | GSTP1 protein affects the susceptibility to Triethylenephosphoramide | affects response to substance | 19076156 |
| C010360 | triethyllead | triethyllead results in increased expression of GSTP1 mRNA | increases expression | 9020200 |
| C052920 | trimethylarsine oxide | trimethylarsine oxide results in increased expression of GSTP1 mRNA | increases expression | 17481689 |
| D014303 | Trinitrotoluene | Trinitrotoluene affects the expression of GSTP1 mRNA | affects expression | 21346803 |
| C012085 | tris(2,3-dibromopropyl)phosphate | GSTP1 protein affects the metabolism of tris(2,3-dibromopropyl)phosphate | affects metabolic processing | 8242859 |
| C012085 | tris(2,3-dibromopropyl)phosphate | GSTP1 protein results in increased susceptibility to tris(2,3-dibromopropyl)phosphate | increases response to substance | 8242859 |
| D014315 | Triterpenes | Triterpenes results in increased expression of GSTP1 mRNA | increases expression | 18544911 |
| D001335 | Vehicle Emissions | GSTP1 gene SNP results in increased susceptibility to Vehicle Emissions | increases response to substance | 18950799 |
| C059141 | verlukast | verlukast inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 15999103 |
| D014747 | Vinblastine | GSTP1 protein results in decreased susceptibility to Vinblastine | decreases response to substance | 11455017 |
| C025643 | vinclozolin | vinclozolin results in increased expression of GSTP1 mRNA | increases expression | 18220299 |
| D014750 | Vincristine | GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases response to substance|increases reaction | 10900222 |
| D014750 | Vincristine | GSTP1 protein results in decreased susceptibility to Vincristine | decreases response to substance | 10900222 |
| D014752 | Vinyl Chloride | GSTP1 gene SNP results in increased susceptibility to Vinyl Chloride | increases response to substance | 20100738 |
| D014810 | Vitamin E | [Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA | affects cotreatment|decreases expression | 19244175 |
| D014810 | Vitamin E | Vitamin E results in increased expression of GSTP1 mRNA | increases expression | 19244175 |
| C020174 | WR 1065 | WR 1065 results in decreased expression of GSTP1 mRNA | decreases expression | 12007958 |
| C005881 | zeaxanthin | zeaxanthin binds to GSTP1 protein | affects binding | 15949677 15355982 |
| C403304 | zerumbone | zerumbone results in increased expression of GSTP1 mRNA | increases expression | 15122579 |
| C016837 | zinc chloride | [Cadmium Chloride co-treated with zinc chloride] results in increased expression of GSTP1 protein | affects cotreatment|increases expression | 15602745 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.22 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 2-amino-4,6-dinitrotoluene | 28.60 | 7525203 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 4-amino-2,6-dinitrotoluene | 28.60 | 7525203 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Capsaicin | 28.60 | 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 28.60 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 28.60 | 18769834 | |
| MESH:D000014 | Abnormalities, Drug-Induced | methylmercuric chloride | 28.60 | 6734493 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 28.60 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 28.60 | 15322242 14514962 11752688 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Trinitrotoluene | 28.60 | 7525203 | |
| MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 3.77 | 18769834 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 6.16 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 6.16 | 11192467 | |
| MESH:D017486 | Acneiform Eruptions | Isotretinoin | 4.95 | 16232082 | |
| MESH:D000152 | Acne Vulgaris | Isotretinoin | 4.16 | 16185265 18769834 | |
| MESH:D058186 | Acute Kidney Injury | Capsaicin | 7.71 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 7.71 | 15814532 12690470 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 7.71 | 16538975 | |
| MESH:D055371 | Acute Lung Injury | 1-nitronaphthalene | 15.75 | 15204773 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 15.75 | 20525806 21297076 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 15.75 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 15.75 | 18653653 | |
| MESH:D055371 | Acute Lung Injury | verlukast | 15.75 | 17118201 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 11.51 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 11.51 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 11.51 | 11798837 17638652 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 11.51 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Ethylenethiourea | 11.51 | 7955072 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 11.51 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Vincristine | 11.51 | 19825857 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 11.03 | 10737359 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 11.03 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 11.03 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 11.03 | 6695378 10737359 | |
| MESH:D000236 | Adenoma | resveratrol | 11.03 | 15688382 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.67 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | 2-aminofluorene | 19.16 | 19052882 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 19.16 | 16434500 19052882 18056438 19061943 17162532 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 19.16 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 19.16 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 19.16 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 9.79 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 9.79 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulindac sulfone | 9.79 | 16150858 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.37 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 3.57 | 17306315 16712894 | |
| MESH:D000382 | Agricultural Workers' Diseases | Atrazine | 7.36 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 7.36 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Pesticides | 7.36 | 17119214 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 3.28 | 21441931 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.99 | 15451039 15451040 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.75 | 17887948 | |
| MESH:D000505 | Alopecia | Capsaicin | 5.83 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 5.83 | 15955085 | |
| MESH:D000544 | Alzheimer Disease | 2-butenal | 10.53 | 16538519 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 10.53 | 17570602 15207723 14715435 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 10.53 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 10.53 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 10.53 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 10.53 | 16183991 16162502 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 10.53 | 18759972 | |
| MESH:D019969 | Amphetamine-Related Disorders | marker/mechanism | 15729709 | ||
| MESH:D000690 | Amyotrophic Lateral Sclerosis | 2-butenal | 5.59 | 17319283 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 5.59 | 10965797 | |
| MESH:D000740 | Anemia | 4-chloronitrobenzene | 8.30 | 3710033 | |
| MESH:D000740 | Anemia | Fluorouracil | 8.30 | 15504547 17963324 16511603 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 8.30 | 11748828 | |
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.26 | 14761424 11369114 17661222 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.03 | 17084956 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.52 | 10982225 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.53 | 15513904 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 5.28 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | vinclozolin | 5.28 | 19015723 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 2.79 | 19183758 | |
| MESH:D001145 | Arrhythmias, Cardiac | Quinidine | 4.00 | 18724381 18057881 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 6.51 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 6.51 | 15014928 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 6.75 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 6.75 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 6.75 | 16412693 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 4.12 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 4.12 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 4.12 | 16292516 | |
| MESH:D001249 | Asthma | marker/mechanism | 11994713 16870661 18988661 | ||
| MESH:D001249 | Asthma | epigallocatechin gallate | 5.86 | 16516891 | |
| MESH:D001249 | Asthma | Ozone | 5.86 | 16373670 17854713 | |
| MESH:D001249 | Asthma | Toluene 2,4-Diisocyanate | 5.86 | 6091945 12585506 11742282 18394133 11467998 12762349 11077013 3040596 16210060 170078 15855793 15590891 6091946 19187332 16792590 7684630 12684321 10934080 20032816 17015710 10797510 15590890 8156442 | |
| MESH:D001249 | Asthma | Tretinoin | 5.86 | 16456186 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 3.66 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 7.94 | 17363696 16126721 16037261 | |
| MESH:D050197 | Atherosclerosis | Asbestos | 7.94 | 18795166 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 7.94 | 18704882 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 7.94 | 17967414 16873680 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Fatty Acids, Omega-3 | 5.96 | 18448859 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Pesticides | 5.96 | 20478945 | |
| MESH:D001321 | Autistic Disorder | marker/mechanism | 17404132 | ||
| MESH:D001321 | Autistic Disorder | Acetaminophen | 2.50 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Cysteine | 2.50 | 19267885 16917939 19056591 | |
| MESH:D001321 | Autistic Disorder | Fatty Acids, Omega-3 | 2.50 | 16920077 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 2.50 | 19056591 16917939 19267885 18929414 | |
| MESH:D001321 | Autistic Disorder | Haloperidol | 2.50 | 19368416 18080171 | |
| MESH:D001321 | Autistic Disorder | Pesticides | 2.50 | 17938740 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 15.45 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 15.45 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 15.45 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 15.45 | 19761891 | |
| MESH:D053713 | Azoospermia | 1,2-dibromo-3-chloropropane | 5.36 | 73955 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 3.13 | 16935849 | |
| MESH:D001661 | Biliary Tract Neoplasms | Vinyl Chloride | 5.53 | 11024202 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 16.21 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 16.21 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 16.21 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Thioacetamide | 16.21 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 16.21 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.47 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.77 | 15746008 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 3.90 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 18.58 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 18.58 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 18.58 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 18.58 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 3.34 | 15867366 | |
| MESH:D001919 | Bradycardia | Capsaicin | 3.77 | 18207255 | |
| MESH:D002545 | Brain Ischemia | Capsaicin | 13.77 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 13.77 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 13.77 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 13.77 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Carmustine | 11.33 | 16187019 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 11.33 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 11.33 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Vinyl Chloride | 11.33 | 12562636 | |
| MESH:D001943 | Breast Neoplasms | 1,2-dibromo-3-chloropropane | 22.56 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Acrylamide | 22.56 | 18183576 16253758 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 22.56 | 11921183 17162533 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 22.56 | 17474063 20146248 | |
| MESH:D001943 | Breast Neoplasms | Cacodylic Acid | 22.56 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | captafol | 22.56 | 8441825 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 22.56 | 18382427 19526202 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 22.56 | 19250217 16243823 18593918 18462866 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 22.56 | 17388661 15093573 11325840 16978400 18234424 18323546 15136595 12006526 17020986 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 22.56 | 18320071 19208741 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 22.56 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | docetaxel | 22.56 | 18628466 15567936 16264153 17369602 19526202 16495393 15692762 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 22.56 | 16935488 19526202 18382427 16264153 15136595 16096432 15993339 18628466 17369602 18234424 16322301 15939500 16115903 18695136 17426702 11325840 16826403 15668708 15567936 15692762 15634643 16595493 17983394 15994142 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 22.56 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 22.56 | 16595493 19217205 18608205 15136595 16557594 16110121 18357371 | |
| MESH:D001943 | Breast Neoplasms | Hexachlorobenzene | 22.56 | 12709520 15061365 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 22.56 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | methyleugenol | 22.56 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 22.56 | 18234424 15136595 16115903 18323546 18223236 16273361 11325840 16244791 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 22.56 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 22.56 | 17534123 17651959 16393696 | |
| MESH:D001943 | Breast Neoplasms | Styrene | 22.56 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 22.56 | 20005174 19084267 20390343 15565566 20859285 19115204 18821012 15668708 19066611 19011961 18997820 18815881 16873071 17893378 19487384 18351453 19410462 19221464 18425577 19142967 19200415 18855134 17440819 19189212 19244106 16202921 19288272 19189210 17049068 18629630 17242785 16273361 17261762 20135344 20544844 19155303 21138602 11161223 19289846 20065188 18984771 19103187 16818667 19059307 21152245 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 22.56 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Toluene 2,4-Diisocyanate | 22.56 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 22.56 | 16873071 16443354 16166294 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 8.07 | 16777450 18315731 17626835 19059883 14754758 15516495 18417511 | |
| MESH:D016535 | Bronchial Hyperreactivity | Toluene 2,4-Diisocyanate | 8.07 | 12507178 15590891 8156442 | |
| MESH:D016535 | Bronchial Hyperreactivity | verlukast | 8.07 | 12654629 | |
| MESH:D001986 | Bronchial Spasm | verlukast | 4.88 | 11432448 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.28 | 16813970 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.08 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 3.37 | 16374292 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 4.01 | 9625245 | |
| MESH:D002100 | Cachexia | Ozone | 3.43 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.21 | 16962696 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 5.71 | 10355542 15721981 16011737 15673190 16097048 16227642 16050911 15700767 16124888 18705752 16192424 3786805 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 5.71 | 16050911 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 7.96 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 7.96 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 7.51 | 18593918 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 7.51 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 7.51 | 16835633 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.21 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.82 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 9029167 | ||
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 45.30 | 3084413 10737359 17761372 3581430 6705139 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-aminofluorene | 45.30 | 19052882 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 45.30 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 45.30 | 21507988 12619106 12907637 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 45.30 | 15553829 14691202 11135700 16217749 15073043 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 45.30 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 45.30 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 45.30 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 45.30 | 16288022 11831363 10672840 10737359 18788625 16698587 18210153 20101231 16569478 18665156 16935385 19107877 19701751 19383236 17978847 20512989 19052882 20432363 18393292 16830150 19539802 16807293 17173139 20935162 16878318 16681979 18506893 18056438 19171122 18785209 20727157 19418558 20514400 17428255 17138121 19394651 16328049 17162532 17055752 20084675 19919837 20524982 20214788 16540662 19208518 19519916 3084413 18971187 17761372 18978308 16502159 18494052 20007298 18691550 16779866 19335982 19822196 21159647 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 45.30 | 16023760 16234567 17876044 18059187 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 45.30 | 15763234 18788625 15289165 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethoxyquin | 45.30 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 45.30 | 17045692 17971768 16799960 17088986 18930000 16332177 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 45.30 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 45.30 | 20007298 17173139 1701930 6705139 20935162 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 45.30 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 45.30 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 45.30 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 45.30 | 17306315 16507464 15276417 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 45.30 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thioacetamide | 45.30 | 17997003 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 45.30 | 1917145 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Vinyl Chloride | 45.30 | 12958735 10699891 12828392 15289165 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 7.16 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 7.16 | 16675471 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 14.45 | 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 14.45 | 12023789 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 14.45 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | docetaxel | 14.45 | 11894018 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulfinosine | 14.45 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 14.45 | 12391285 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfone | 14.45 | 18758305 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.66 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.54 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 14.27 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 14.27 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 14.27 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 14.27 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Vinblastine | 14.27 | 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Vincristine | 14.27 | 16201981 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.92 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 28.78 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 28.78 | 17066447 6189445 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 28.78 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 28.78 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 28.78 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 28.78 | 17066447 18986760 16757204 16280240 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 28.78 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 28.78 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 28.78 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 28.78 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 28.78 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 28.78 | 16096774 16051514 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Vincristine | 28.78 | 6189445 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 2.44 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 8.75 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 8.75 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 8.75 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 8.75 | 18670907 18850075 16120746 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 2.55 | 15505089 17131338 18627295 16612575 17351982 17519947 16731534 16364871 16269455 16455267 17308081 17974986 16109756 17382496 16651473 16242529 15476868 17928571 17329180 15811867 17924179 16952015 17007740 16278810 15792986 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 2.31 | 16243910 17334414 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 6.42 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 6.42 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 6.42 | 15458977 | |
| MESH:D002340 | Carotid Artery Diseases | marker/mechanism | 16973168 | ||
| MESH:D002375 | Catalepsy | Haloperidol | 3.61 | 15215559 1977408 | |
| MESH:D002386 | Cataract | 4-amino-2,6-dinitrotoluene | 9.83 | 14694615 | |
| MESH:D002386 | Cataract | Acetaminophen | 9.83 | 10977129 | |
| MESH:D002386 | Cataract | Tretinoin | 9.83 | 17460283 | |
| MESH:D002386 | Cataract | Trinitrotoluene | 9.83 | 14694615 15817613 | |
| MESH:D002418 | Cattle Diseases | Acrylamide | 4.14 | 12510666 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7.71 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 7.71 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 7.71 | 17174075 2727394 21159647 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 7.71 | 20056578 19524636 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 2.97 | 4080065 | |
| MESH:D002547 | Cerebral Palsy | Toluene | 4.53 | 9294310 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 3.28 | 16129372 | |
| MESH:D018281 | Cholangiocarcinoma | 2-aminofluorene | 13.64 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 13.64 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 13.64 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thioacetamide | 13.64 | 18291259 | |
| MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 4.86 | 12912871 | |
| MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 4.70 | 16629650 19486331 12927374 15913567 7624871 15500046 18164287 18590720 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 4.70 | 19176532 | |
| MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 4.52 | 19407337 10220858 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.82 | 16461808 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.46 | 15894690 | |
| MESH:D016770 | Ciliophora Infections | Pyrimethamine | 7.35 | 12113305 | |
| MESH:D016770 | Ciliophora Infections | Quinine | 7.35 | 12113305 | |
| MESH:D002971 | Cleft Lip | Ethanol | 2.71 | 15513904 | |
| MESH:D002972 | Cleft Palate | Ethanol | 5.22 | 15513904 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 5.22 | 16354765 15340226 12621046 8697196 15668235 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 5.22 | 9407595 | |
| MESH:D003092 | Colitis | Curcumin | 12.52 | 16804969 16782535 18200517 | |
| MESH:D003092 | Colitis | resveratrol | 12.52 | 16474422 | |
| MESH:D003092 | Colitis | Selenium | 12.52 | 17936198 | |
| MESH:D003092 | Colitis | Tretinoin | 12.52 | 17035595 | |
| MESH:D003093 | Colitis, Ulcerative | Dinitrochlorobenzene | 4.27 | 17373747 19159591 | |
| MESH:D003093 | Colitis, Ulcerative | phenethyl isothiocyanate | 4.27 | 20423518 | |
| MESH:D003103 | Coloboma | Curcumin | 3.33 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 21.01 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 21.01 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 21.01 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 21.01 | 17510524 16343908 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 21.01 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 21.01 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Deoxycholic Acid | 21.01 | 16213893 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 21.01 | 16340194 15001691 17018589 16510598 18772588 17725105 17016597 17172411 17287894 17169374 | |
| MESH:D003110 | Colonic Neoplasms | oxaliplatin | 21.01 | 16510598 16004971 16024531 | |
| MESH:D003110 | Colonic Neoplasms | polyphenols | 21.01 | 16293270 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 21.01 | 17148506 11134977 16640504 19440933 17191121 15741050 19056647 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 21.01 | 16338953 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 15.70 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 15.70 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 15.70 | 18349538 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 15.70 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 15.70 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 15.70 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 15.70 | 16331619 15148649 16282729 14970324 17401013 17016601 16303861 17255274 20501625 17594712 17454858 18949393 18802399 18288408 17695437 18448328 18509181 16391804 18383874 15289873 16524972 17094418 | |
| MESH:D015179 | Colorectal Neoplasms | oxaliplatin | 15.70 | 17594712 17401013 18448328 18509181 17255274 17695437 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 15.70 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 15.70 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 15.70 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | sulindac sulfone | 15.70 | 18059344 10416599 11197048 10666051 | |
| MESH:D015179 | Colorectal Neoplasms | Vinblastine | 15.70 | 18802399 | |
| MESH:D000013 | Congenital Abnormalities | 2-amino-4,6-dinitrotoluene | 12.76 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | 4-amino-2,6-dinitrotoluene | 12.76 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 12.76 | 14669216 17141729 | |
| MESH:D000013 | Congenital Abnormalities | Trinitrotoluene | 12.76 | 15095906 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 3.61 | 18497527 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.76 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.93 | 12609071 | |
| MESH:D003328 | Coronary Thrombosis | methyleugenol | 4.51 | 16048847 | |
| MESH:D003371 | Cough | Capsaicin | 3.86 | 10350223 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 11.40 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 11.40 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 11.40 | 11873399 19302082 11198716 15451039 10194807 15451040 15513904 | |
| MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 11.40 | 9879862 18769834 | |
| MESH:D019465 | Craniofacial Abnormalities | lead acetate | 11.40 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | sodium arsenate | 11.40 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 11.40 | 20055451 10048152 15322242 | |
| MESH:D019465 | Craniofacial Abnormalities | Toluene | 11.40 | 9294310 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 11.40 | 9224671 14991402 9211117 17551590 9142499 16925845 9125849 9664655 8800419 10589399 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 11.40 | 19769572 | |
| MESH:D003456 | Cryptorchidism | vinclozolin | 3.08 | 14966744 | |
| MESH:D003490 | Cyanosis | Trinitrotoluene | 3.64 | 18551238 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 3.35 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 7.70 | 12161096 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 7.70 | 15276878 10700343 16413132 12161096 16614059 16651033 10498854 18483878 12388444 11948286 18372110 16989017 15643279 18710439 18093676 17979934 12913760 18295254 18433785 17010015 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.48 | 16733453 | |
| MESH:D003643 | Death | Toluene | 4.34 | 6431079 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 6.81 | 15213294 | |
| MESH:D016757 | Death, Sudden, Cardiac | Haloperidol | 6.81 | 20210726 | |
| MESH:D003704 | Dementia | Haloperidol | 3.38 | 11575062 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.07 | 19031437 | |
| MESH:D003866 | Depressive Disorder | Amitriptyline | 10.01 | 18083778 15014590 | |
| MESH:D003866 | Depressive Disorder | Clomipramine | 10.01 | 18083778 | |
| MESH:D003866 | Depressive Disorder | Doxepin | 10.01 | 15014590 | |
| MESH:D003866 | Depressive Disorder | Imipramine | 10.01 | 20305041 | |
| MESH:D003872 | Dermatitis | Benzene | 3.49 | 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 5.11 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dinitrochlorobenzene | 5.11 | 15491423 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Toluene 2,4-Diisocyanate | 5.11 | 18759878 15491423 12956900 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.63 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | Toluene 2,4-Diisocyanate | 3.58 | 17010967 | |
| MESH:D009783 | Dermatitis, Occupational | Vinyl Chloride | 4.41 | 10870345 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 2.63 | 16285004 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 7.50 | 11751995 10990075 15331540 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 7.50 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 7.50 | 16873680 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 2.64 | 18772604 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | coumarin | 7.30 | 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 7.30 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 7.30 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 7.30 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 7.30 | 17107852 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 12.01 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 12.01 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 12.01 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 12.01 | 19279558 | |
| MESH:D004342 | Drug Hypersensitivity | marker/mechanism | 20485159 | ||
| MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 54.55 | 7624871 17522070 20133375 18289764 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1-nitronaphthalene | 54.55 | 8212003 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2-amino-4,6-dinitrotoluene | 54.55 | 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | 4-amino-2,6-dinitrotoluene | 54.55 | 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 54.55 | 11743745 16781746 14550746 19739265 12540782 11287661 12392966 12705907 19370779 14725611 12153990 16177239 2444490 11461765 12594235 17906064 17562736 17522070 19420014 15968718 11739529 11421492 16393943 10915739 18713872 19416960 11529661 18071297 16485898 16227642 10663392 19085960 19164858 15619225 10774834 12958197 19923254 11834606 16081117 14986274 16109766 | |
| MESH:D056486 | Drug-Induced Liver Injury | bicyclol | 54.55 | 15998439 | |
| MESH:D056486 | Drug-Induced Liver Injury | bromobenzene | 54.55 | 12628495 10092053 | |
| MESH:D056486 | Drug-Induced Liver Injury | captafol | 54.55 | 1765226 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 54.55 | 7440962 3732212 15968718 11566570 19085960 6623471 17522070 6884620 21278145 19336974 4309450 15998439 16177239 3786805 2869522 15027814 9327722 7179309 16227642 10092053 10915739 7120509 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 54.55 | 17851650 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 54.55 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylformamide | 54.55 | 3732212 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 54.55 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 54.55 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | polyphenols | 54.55 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 54.55 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | sodium arsenate | 54.55 | 18186108 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 54.55 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tea | 54.55 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 54.55 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetracycline | 54.55 | 17522070 | |
| MESH:D056486 | Drug-Induced Liver Injury | Thioacetamide | 54.55 | 12963478 | |
| MESH:D056486 | Drug-Induced Liver Injury | Trinitrotoluene | 54.55 | 21346803 18551238 | |
| MESH:D056486 | Drug-Induced Liver Injury | tris(2,3-dibromopropyl)phosphate | 54.55 | 8441998 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.77 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 10.85 | 12231392 15033597 12649298 19839026 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 10.85 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Stavudine | 10.85 | 15040536 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 10.85 | 11462148 | |
| MESH:D004381 | Duodenal Ulcer | Capsaicin | 5.51 | 11535926 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 5.51 | 17351913 | |
| MESH:D004421 | Dystonia | Phenobarbital | 2.77 | 1851702 | |
| MESH:C538011 | Eales disease | Vitamin E | 3.37 | 9068938 | |
| MESH:D004487 | Edema | Amitriptyline | 27.57 | 12798668 | |
| MESH:D004487 | Edema | captafol | 27.57 | 1765226 | |
| MESH:D004487 | Edema | Clomipramine | 27.57 | 12798668 | |
| MESH:D004487 | Edema | Imipramine | 27.57 | 12798668 | |
| MESH:D004487 | Edema | perfluorooctanoic acid | 27.57 | 17259670 12083418 | |
| MESH:D004487 | Edema | pirinixic acid | 27.57 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 27.57 | 12787963 | |
| MESH:D004487 | Edema | resveratrol | 27.57 | 8985016 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 27.57 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 27.57 | 16716910 7812673 15177302 8113982 11698051 8273558 9599246 | |
| MESH:D004487 | Edema | verlukast | 27.57 | 17118201 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 7.55 | 15322242 18230668 16714409 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 7.55 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 8.42 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 8.42 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 8.42 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 9.62 | 19294695 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 9.62 | 19294695 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 9.58 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Ethylenethiourea | 9.58 | 7955072 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 9.58 | 20544844 17893378 16202921 19155303 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 9.58 | 16569247 | |
| MESH:D004715 | Endometriosis | celecoxib | 5.44 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 5.44 | 9294722 10568697 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 9.65 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 9.65 | 15268973 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 3.11 | 15821434 15328337 17637181 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 3.56 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 5.29 | 11006010 | |
| MESH:D004802 | Eosinophilia | Toluene 2,4-Diisocyanate | 5.29 | 8156442 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 2.83 | 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 2.57 | 3922381 11558140 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 4.03 | 20417680 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 4.03 | 19700373 19439326 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 2.40 | 6401628 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 2.97 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 2.73 | 3659116 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.78 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Capsaicin | 4.39 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 14.30 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 14.30 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 14.30 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 14.30 | 17638652 15464296 16785472 15173087 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | docetaxel | 14.30 | 16337965 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 14.30 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 14.30 | 17638652 15173087 16481741 16337965 16785472 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 14.30 | 16481741 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 5.20 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 5.20 | 9664655 16938888 | |
| MESH:D005128 | Eye Diseases | Toluene 2,4-Diisocyanate | 4.43 | 18447907 | |
| MESH:D005198 | Fanconi Syndrome | Ifosfamide | 5.28 | 17481685 | |
| MESH:D005218 | Fat Necrosis | Thioacetamide | 4.38 | 16456712 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 43.11 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 43.11 | 18296743 | |
| MESH:D005234 | Fatty Liver | bicyclol | 43.11 | 16409862 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 43.11 | 16045604 15959796 17595544 12631006 16239168 12795759 61145 19224547 | |
| MESH:D005234 | Fatty Liver | Curcumin | 43.11 | 19297423 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 43.11 | 21071580 20387270 | |
| MESH:D005234 | Fatty Liver | Ethanol | 43.11 | 16409862 19236843 18620774 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 43.11 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 43.11 | 15975614 | |
| MESH:D005234 | Fatty Liver | Stavudine | 43.11 | 18299183 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 43.11 | 19224547 14986274 | |
| MESH:D005234 | Fatty Liver | Tetracycline | 43.11 | 19224547 16917069 | |
| MESH:D005234 | Fatty Liver | Vinyl Chloride | 43.11 | 12197357 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.33 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.27 | 16709447 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.98 | 16946407 15513904 10194807 15451040 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.18 | 11858732 | |
| MESH:D005317 | Fetal Growth Retardation | lead acetate | 4.12 | 19769572 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 2.85 | 9205823 11852909 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.22 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 7.11 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 7.11 | 19069698 | |
| MESH:D005355 | Fibrosis | arsenite | 22.44 | 18296743 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 22.44 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 22.44 | 18705752 | |
| MESH:D005355 | Fibrosis | Emodin | 22.44 | 19474275 | |
| MESH:D005355 | Fibrosis | Quercetin | 22.44 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 22.44 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 22.44 | 17994277 | |
| MESH:D005393 | Fish Diseases | Pyrimethamine | 7.23 | 12113305 | |
| MESH:D005393 | Fish Diseases | Quinine | 7.23 | 12113305 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.00 | 16904648 | |
| MESH:D005756 | Gastritis | Acetaminophen | 6.75 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 6.75 | 15046732 | |
| MESH:D005770 | Gastrointestinal Neoplasms | captafol | 12.55 | 8441825 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Captan | 12.55 | 8441825 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 12.55 | 18462866 | |
| MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 3.62 | 16973722 | |
| MESH:D005832 | Genital Diseases, Male | vinclozolin | 3.96 | 16417039 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 3.37 | 16452187 | |
| MESH:D005909 | Glioblastoma | Capsaicin | 18.18 | 18405923 | |
| MESH:D005909 | Glioblastoma | Carmustine | 18.18 | 16187019 | |
| MESH:D005909 | Glioblastoma | Curcumin | 18.18 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 18.18 | 17150277 | |
| MESH:D005909 | Glioblastoma | Quercetin | 18.18 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 18.18 | 17312396 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 18.18 | 18801729 | |
| MESH:D005910 | Glioma | marker/mechanism | 16899598 | ||
| MESH:D005910 | Glioma | Fluorouracil | 3.66 | 16145905 | |
| MESH:D005910 | Glioma | Quercetin | 3.66 | 17643826 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 4.20 | 11389073 | |
| MESH:D005911 | Gliosis | Paraquat | 3.83 | 11124998 | |
| MESH:D018149 | Glucose Intolerance | sodium arsenate | 3.84 | 19446573 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.26 | 10696789 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 3.75 | 16376943 11014644 15172196 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 16.93 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 16.93 | 18462866 18829502 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 16.93 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 16.93 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 16.93 | 15162350 15102660 18337622 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 16.93 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 6.59 | 19898482 | |
| MESH:D034381 | Hearing Loss | Styrene | 6.59 | 17420221 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.82 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.26 | 15464296 | |
| MESH:D006356 | Heartburn | Capsaicin | 4.39 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | 2,3,7,8-tetrachlorodibenzofuran | 11.49 | 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 11.49 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 11.49 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 11.49 | 14991402 9664655 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 11.49 | 16080930 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 2.49 | 14766674 16330681 16244372 16144979 16879835 16244371 16495754 18674790 17875725 12587719 18006777 16707910 17888722 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 8.88 | 17481944 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 8.88 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 8.88 | 18097624 | |
| MESH:D006333 | Heart Failure | Selenium | 8.88 | 17162251 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 8.70 | 6705139 | |
| MESH:D006390 | Hemangioendothelioma | Vinyl Chloride | 8.70 | 15380572 | |
| MESH:D006393 | Hemangiopericytoma | Vinyl Chloride | 5.53 | 10964802 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 8.55 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 8.55 | 15692506 | |
| MESH:D006394 | Hemangiosarcoma | Vinyl Chloride | 8.55 | 12828392 12762079 15989139 15999577 12211074 12958735 11217710 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 3.42 | 16183116 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.19 | 16366002 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 4.00 | 11918545 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.13 | 11000095 | |
| MESH:D006486 | Hemosiderosis | 4-chloronitrobenzene | 5.51 | 3710033 | |
| MESH:D006501 | Hepatic Encephalopathy | Thioacetamide | 3.36 | 18665440 15929193 17276928 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Busulfan | 10.36 | 14986274 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 10.36 | 14986274 | |
| MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 8.69 | 18590720 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 8.69 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | Thioacetamide | 8.69 | 16456712 | |
| MESH:D006521 | Hepatitis, Chronic | Methyldopa | 5.35 | 14986274 | |
| MESH:D006529 | Hepatomegaly | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | 17.65 | 16109766 | |
| MESH:D006529 | Hepatomegaly | perfluorooctanoic acid | 17.65 | 3609246 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 17.65 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 17.65 | 19176532 16221962 18467677 19772884 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 17.65 | 15340226 12621046 16120746 | |
| MESH:D006529 | Hepatomegaly | Trinitrotoluene | 17.65 | 15817613 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.75 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 2.06 | 16863852 16490937 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 9.13 | 10809021 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 9.13 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 9.13 | 16876885 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 4.45 | 12878215 | |
| MESH:D015658 | HIV Infections | Stavudine | 4.45 | 11141242 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 20.50 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 20.50 | 16135485 17606976 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 20.50 | 17606976 15147373 18501091 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 20.50 | 18180244 17606976 16200630 16135485 15147373 | |
| MESH:D006689 | Hodgkin Disease | Ifosfamide | 20.50 | 16135485 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 20.50 | 12676792 | |
| MESH:D006689 | Hodgkin Disease | Vinblastine | 20.50 | 18501091 18180244 | |
| MESH:D006689 | Hodgkin Disease | Vincristine | 20.50 | 15147373 16794504 16135485 17606976 | |
| MESH:D006734 | Horse Diseases | Thiabendazole | 4.95 | 16402567 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 6.06 | 17454163 16566672 14716179 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 6.06 | 14716179 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.72 | 16959395 15340226 18606429 8697196 16354765 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 16.26 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Capsaicin | 16.26 | 17434803 17043245 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 16.26 | 18783367 | |
| MESH:D006930 | Hyperalgesia | oxaliplatin | 16.26 | 17418472 | |
| MESH:D006930 | Hyperalgesia | perfluorooctanoic acid | 16.26 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 16.26 | 16870215 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.22 | 16899240 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 5.40 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 5.40 | 17188708 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.28 | 16778211 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 8.96 | 18262572 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 8.96 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 8.96 | 18262572 11834736 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 3.31 | 16484555 | |
| MESH:D006948 | Hyperkinesis | Methamphetamine | 4.21 | 17658665 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 5.55 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 5.55 | 16873680 | |
| MESH:D017495 | Hyperpigmentation | 1-phenylazo-2-naphthol | 5.92 | 1402006 | |
| MESH:D006967 | Hypersensitivity | Butylated Hydroxytoluene | 5.51 | 17604070 | |
| MESH:D006967 | Hypersensitivity | Toluene 2,4-Diisocyanate | 5.51 | 11019492 10880147 | |
| MESH:D006968 | Hypersensitivity, Delayed | indirubin | 4.61 | 11275354 | |
| MESH:D006973 | Hypertension | Benzene | 4.40 | 17940673 | |
| MESH:D006973 | Hypertension | Quercetin | 4.40 | 18356687 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 4.40 | 18850075 18670907 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 2.81 | 15338365 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Hydralazine | 3.34 | 16612254 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 3.11 | 17488730 | |
| MESH:D007022 | Hypotension | Dopamine | 3.82 | 6740701 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 4.00 | 16076520 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 3.36 | 17600658 | |
| MESH:D007247 | Infertility, Female | Acrylamide | 3.98 | 11020651 | |
| MESH:D007248 | Infertility, Male | Acrylamide | 19.65 | 11020651 12507653 15355880 15749267 | |
| MESH:D007248 | Infertility, Male | Atrazine | 19.65 | 12948887 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 19.65 | 16517039 7193160 | |
| MESH:D007248 | Infertility, Male | decitabine | 19.65 | 17581917 | |
| MESH:D007248 | Infertility, Male | Paraquat | 19.65 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 19.65 | 12646999 15346721 | |
| MESH:D007248 | Infertility, Male | Trinitrotoluene | 19.65 | 12150543 | |
| MESH:D007248 | Infertility, Male | vinclozolin | 19.65 | 16467254 | |
| MESH:D007249 | Inflammation | Amitriptyline | 38.98 | 12798668 | |
| MESH:D007249 | Inflammation | Capsaicin | 38.98 | 16956363 | |
| MESH:D007249 | Inflammation | Clomipramine | 38.98 | 12798668 | |
| MESH:D007249 | Inflammation | Curcumin | 38.98 | 17151092 18403477 16956363 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 38.98 | 18785209 | |
| MESH:D007249 | Inflammation | Fatty Acids, Omega-3 | 38.98 | 17296493 | |
| MESH:D007249 | Inflammation | Flavonoids | 38.98 | 17296493 | |
| MESH:D007249 | Inflammation | Imipramine | 38.98 | 12798668 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 38.98 | 12878042 9205823 17237260 17963957 17255318 | |
| MESH:D007249 | Inflammation | perfluorooctanoic acid | 38.98 | 12083418 | |
| MESH:D007249 | Inflammation | Plant Extracts | 38.98 | 15997105 12787963 19332304 16366677 | |
| MESH:D007249 | Inflammation | polyphenols | 38.98 | 16366677 | |
| MESH:D007249 | Inflammation | resveratrol | 38.98 | 16366677 | |
| MESH:D007249 | Inflammation | Tamoxifen | 38.98 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 38.98 | 12878042 12200463 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 38.98 | 8273558 7812673 15177302 7562506 11698051 | |
| MESH:D007249 | Inflammation | verlukast | 38.98 | 17118201 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.49 | 18596194 18200517 | |
| MESH:D007251 | Influenza, Human | Quercetin | 15.93 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 15.93 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 15.93 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 15.93 | 16624496 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 3.98 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 3.98 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 2.51 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 9.69 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 9.69 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 9.69 | 12628509 12584176 12351151 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 3.39 | 17255318 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 10.19 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 10.19 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 10.19 | 15992940 17551590 | |
| MESH:D007627 | Keloid | Quercetin | 3.66 | 17086741 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.81 | 15464296 | |
| MESH:D007674 | Kidney Diseases | 2-dichlorobenzene | 34.13 | 8440869 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 34.13 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 34.13 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 34.13 | 16962696 | |
| MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 34.13 | 15369732 | |
| MESH:D007674 | Kidney Diseases | captafol | 34.13 | 1765226 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 34.13 | 12231392 12649298 18289764 19839026 15190930 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 34.13 | 15369732 15699352 16775033 | |
| MESH:D007674 | Kidney Diseases | Ifosfamide | 34.13 | 16221203 17035713 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 34.13 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 34.13 | 20008137 | |
| MESH:D007674 | Kidney Diseases | tris(2,3-dibromopropyl)phosphate | 34.13 | 3883695 3230254 3356864 8441998 3611594 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 34.13 | 12488133 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 9.77 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 9.77 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 9.77 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | captafol | 14.74 | 8441825 | |
| MESH:D007680 | Kidney Neoplasms | Captan | 14.74 | 8441825 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 14.74 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 14.74 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | tris(2,3-dibromopropyl)phosphate | 14.74 | 8991072 | |
| MESH:D007680 | Kidney Neoplasms | Vinyl Chloride | 14.74 | 12562636 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.47 | 11231351 | |
| MESH:D007859 | Learning Disorders | Ethanol | 2.96 | 15451040 | |
| MESH:D007889 | Leiomyoma | Curcumin | 3.33 | 18555241 | |
| MESH:D007898 | Leishmaniasis, Visceral | artemisinine | 4.11 | 20403680 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 19.64 | 15070760 | |
| MESH:D007938 | Leukemia | Benzene | 19.64 | 18335105 15935818 14694614 17119257 | |
| MESH:D007938 | Leukemia | Curcumin | 19.64 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 19.64 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 19.64 | 18980019 19235587 | |
| MESH:D007938 | Leukemia | kaempferol | 19.64 | 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 19.64 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 19.64 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.82 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 2.75 | 17658394 18172266 18587576 17802794 17008537 17296974 | |
| MESH:D007945 | Leukemia, Lymphoid | Thiotepa | 4.97 | 10069464 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 9.43 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 9.43 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Emodin | 9.43 | 17077332 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 7.40 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 7.40 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | marker/mechanism | 20843134 | ||
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 11.34 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Busulfan | 11.34 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 11.34 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Thiotepa | 11.34 | 10373061 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 17.28 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 17.28 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 17.28 | 18454857 19117987 17236224 | |
| MESH:D007951 | Leukemia, Myeloid | Thiotepa | 17.28 | 10069464 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 17.28 | 16482212 16932348 19285840 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 6.35 | 16467208 20471514 19850784 17050201 16968895 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 6.35 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 6.35 | 18704418 18460780 18206229 19010910 19387464 17679729 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 6.35 | 16294345 19850784 17596541 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 6.35 | 18206229 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.13 | 18055864 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 13.20 | 19075265 19225113 12712474 12018890 16823087 12679006 17107899 15622746 19642359 15748426 17649720 16966277 17712046 17217047 16891316 16331271 15213294 15336539 9834237 11161223 16112521 17869043 11468182 16330433 19035177 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 13.20 | 16766008 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 13.20 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Thiophenes | 13.20 | 16140954 16140955 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 13.20 | 9834237 19642359 16140955 16891316 16331271 19035177 15748426 17294898 16935935 16823087 17506722 17107899 12679006 17361223 19029980 17339181 19225113 16788101 16766008 17649720 17301526 17712046 17368321 19075265 17217047 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.52 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.52 | 16106398 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 7.44 | 11830472 10052129 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 7.44 | 15821434 | |
| MESH:D007984 | Leydig Cell Tumor | perfluorooctanoic acid | 8.60 | 8812269 | |
| MESH:D007984 | Leydig Cell Tumor | vinclozolin | 8.60 | 16417039 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 4.79 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 4.79 | 9224671 | |
| MESH:D008064 | Lipidoses | Amitriptyline | 10.27 | 17567588 15342952 | |
| MESH:D008064 | Lipidoses | Clomipramine | 10.27 | 15342952 17567588 | |
| MESH:D008064 | Lipidoses | Imipramine | 10.27 | 15342952 17567588 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 10.27 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.58 | 17353645 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 17.22 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 17.22 | 17174718 16943688 16221502 11408273 21278145 16239168 11903743 17157831 17334410 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 17.22 | 20032147 19638242 18522880 18407596 18665156 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 17.22 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 17.22 | 21047994 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 17.22 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | Vinyl Chloride | 17.22 | 11679801 15289165 12958735 12499459 15354062 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.78 | 18295389 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | bicyclol | 25.34 | 16603200 15730626 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 25.34 | 16015684 18166357 16027843 14716833 15818738 17944888 16136751 18705752 18376398 18395095 18472094 16097048 12898905 18481824 14748882 17900296 17761835 15057751 17714472 16638106 18395914 16033810 15370692 18420326 15925388 12609069 17708605 13678700 12389079 18263696 16248980 17640975 15730626 15650968 17922224 18429990 17557913 17721639 18412020 15893842 15931870 12445421 18210741 12958196 12649538 15996030 14512876 12741479 14620537 18205269 18277467 20821823 17823541 11481614 17698563 12586293 12632514 10355542 12546737 15052691 18472332 18418968 12666154 17525996 17805973 15876570 18156304 15362042 18054572 18339082 17869086 18187930 15338365 17565644 18006644 18279442 12445418 12667390 17481882 16011737 18251166 16116963 14716496 17766677 15673190 17976157 15123356 18317297 15959796 14724832 16192424 12632512 17631135 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 25.34 | 17355460 18705752 18006644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Cysteine | 25.34 | 15158331 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 25.34 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Emodin | 25.34 | 15288473 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 25.34 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 25.34 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 25.34 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | oltipraz | 25.34 | 16544323 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 25.34 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 25.34 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 25.34 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 25.34 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 25.34 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thioacetamide | 25.34 | 12175628 16511523 17127702 15474484 12531686 18380797 10677585 18606216 18263696 16126171 15334695 16248980 15465738 11172339 12679928 17629604 14739098 15716488 16098781 15158331 16097051 12085344 11481614 18615449 12891558 18032466 15362042 18031379 16489207 17292413 15288473 15095483 18416461 15288472 15075984 11682029 18395095 15316131 18295389 12557150 17050028 16343077 15078482 17355460 18458672 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 25.34 | 16248980 18397230 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 25.34 | 16169303 | |
| MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 27.68 | 17184895 | |
| MESH:D008107 | Liver Diseases | 2-dichlorobenzene | 27.68 | 1853346 8661352 1949037 8440869 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 27.68 | 19784758 11587558 19460945 12587719 16611625 19014921 12969438 16610002 | |
| MESH:D008107 | Liver Diseases | Capsaicin | 27.68 | 16956363 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 27.68 | 16964402 15830285 17285989 15720792 16246199 | |
| MESH:D008107 | Liver Diseases | Curcumin | 27.68 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 27.68 | 17034775 | |
| MESH:D008107 | Liver Diseases | Hemin | 27.68 | 17173083 | |
| MESH:D008107 | Liver Diseases | pentachlorobenzene | 27.68 | 1949037 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 27.68 | 19363144 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 27.68 | 17034775 | |
| MESH:D008107 | Liver Diseases | polyphenols | 27.68 | 16698588 | |
| MESH:D008107 | Liver Diseases | Thioacetamide | 27.68 | 15158337 18374380 16337175 | |
| MESH:D008107 | Liver Diseases | Vinyl Chloride | 27.68 | 16270392 15211785 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 3.37 | 17207112 17347304 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 7.58 | 15123358 | |
| MESH:D017093 | Liver Failure | Stavudine | 7.58 | 18299183 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 9.39 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 9.39 | 14706259 16899240 | |
| MESH:D017114 | Liver Failure, Acute | Thioacetamide | 9.39 | 15633222 12479984 17276928 15313186 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 65.47 | 16273603 11376686 10672840 10737359 18001218 14678523 | |
| MESH:D008113 | Liver Neoplasms | 2-aminofluorene | 65.47 | 19499222 20492335 20452335 19850985 | |
| MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 65.47 | 2125692 15890375 9163691 18177683 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 65.47 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 65.47 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 65.47 | 19389873 21295105 | |
| MESH:D008113 | Liver Neoplasms | Butylated Hydroxytoluene | 65.47 | 18177683 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 65.47 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 65.47 | 19850985 18754104 20501860 15175105 18978307 18644402 20583210 18648771 20434301 2422723 19255062 20452335 19256749 12112319 19996281 20137499 15885732 19638242 19833225 12771043 9163691 19499222 20118626 20101389 21071580 18977376 21167192 19294768 20492335 19812893 10737359 19090486 19642983 19690152 20405173 19254457 2862719 19073162 19551842 19426721 19427195 21047994 16942905 21278145 | |
| MESH:D008113 | Liver Neoplasms | Ethylenethiourea | 65.47 | 11940454 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 65.47 | 16603448 17045692 18383874 15113037 | |
| MESH:D008113 | Liver Neoplasms | Mitomycin | 65.47 | 15113037 | |
| MESH:D008113 | Liver Neoplasms | perfluorooctanoic acid | 65.47 | 18709148 14757943 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 65.47 | 15975961 19812893 19073162 21047994 8742319 19482888 | |
| MESH:D008113 | Liver Neoplasms | Piperonyl Butoxide | 65.47 | 18648771 19690152 20101389 15890375 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 65.47 | 15890375 20007298 16377806 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 65.47 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 65.47 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 65.47 | 20405173 19812893 19321006 19073162 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 65.47 | 16712894 15276417 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 65.47 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 65.47 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | tris(2,3-dibromopropyl)phosphate | 65.47 | 8991072 | |
| MESH:D008113 | Liver Neoplasms | Vinyl Chloride | 65.47 | 11024202 10964802 12762079 10629081 11679801 15999577 12211074 | |
| MESH:D008113 | Liver Neoplasms | zerumbone | 65.47 | 20452335 | |
| MESH:D008114 | Liver Neoplasms, Experimental | marker/mechanism | 2563599 3124819 | ||
| MESH:D008114 | Liver Neoplasms, Experimental | 1-phenylazo-2-naphthol | 49.95 | 2563599 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 49.95 | 6150874 534488 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 49.95 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 49.95 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 49.95 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 49.95 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | captafol | 49.95 | 8441825 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 49.95 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Deoxycholic Acid | 49.95 | 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 49.95 | 18775883 18093689 18544905 21159647 19539802 18164116 19009564 18282651 16267830 19004024 18079962 18253720 19126423 19519916 3124819 17174075 2563599 17942915 17854601 18308698 9362446 16842330 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 49.95 | 17085340 16842330 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Hexachlorobenzene | 49.95 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | N,N-dimethyl-4-(6-benzothiazolylazo)aniline | 49.95 | 3124819 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 49.95 | 1399818 2563599 17172636 6150874 18308698 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 49.95 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | styrene oxide | 49.95 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 49.95 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vinyl Chloride | 49.95 | 12562636 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 5.07 | 15213294 | |
| MESH:D008133 | Long QT Syndrome | Quinidine | 5.07 | 15350150 11989578 | |
| MESH:D008171 | Lung Diseases | 1-nitronaphthalene | 12.34 | 8212003 | |
| MESH:D008171 | Lung Diseases | Acrolein | 12.34 | 11504702 | |
| MESH:D008171 | Lung Diseases | Ozone | 12.34 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 12.34 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 12.34 | 16863852 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 3.49 | 14698565 | |
| MESH:D055370 | Lung Injury | 1-nitronaphthalene | 11.43 | 2384072 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 11.43 | 21114838 | |
| MESH:D055370 | Lung Injury | naphthalene | 11.43 | 6834280 | |
| MESH:D055370 | Lung Injury | Ozone | 11.43 | 20417186 | |
| MESH:D008175 | Lung Neoplasms | marker/mechanism | 17909032 | ||
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 47.07 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 47.07 | 14755239 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 47.07 | 19825857 11798837 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 47.07 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Asbestos | 47.07 | 12111688 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 47.07 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 47.07 | 6695378 18569708 20064080 20464547 20869020 18816296 20135361 17053015 18520028 | |
| MESH:D008175 | Lung Neoplasms | Butylated Hydroxytoluene | 47.07 | 18597497 16337739 19925653 15390079 19359593 11696405 11246140 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 47.07 | 17225452 11798837 6189445 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 47.07 | 19359593 16243823 18462866 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 47.07 | 20512841 20970405 6695378 21163286 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 47.07 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 47.07 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Isotretinoin | 47.07 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 47.07 | 8597069 7614698 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 47.07 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Polycyclic Hydrocarbons, Aromatic | 47.07 | 10814675 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 47.07 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 47.07 | 16712894 15276417 17306315 17077188 19931552 | |
| MESH:D008175 | Lung Neoplasms | Styrene | 47.07 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 47.07 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 47.07 | 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 47.07 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Vehicle Emissions | 47.07 | 9255578 | |
| MESH:D008175 | Lung Neoplasms | Vincristine | 47.07 | 19825857 6189445 | |
| MESH:D008175 | Lung Neoplasms | Vinyl Chloride | 47.07 | 12958735 12562636 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 47.07 | 11062179 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.48 | 15086387 | |
| MESH:D008223 | Lymphoma | Benzene | 22.89 | 17119257 17584886 | |
| MESH:D008223 | Lymphoma | Chlorambucil | 22.89 | 10745627 | |
| MESH:D008223 | Lymphoma | Curcumin | 22.89 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 22.89 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 22.89 | 19470736 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 22.89 | 16098063 | |
| MESH:D008223 | Lymphoma | Etoposide | 22.89 | 12854902 12556972 | |
| MESH:D008223 | Lymphoma | Thiotepa | 22.89 | 10069464 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 10.10 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 10.10 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 10.10 | 14737004 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 11.42 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 11.42 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 11.42 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 11.42 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 7.30 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 7.30 | 15621674 | |
| MESH:D008288 | Malaria | artemisinine | 4.37 | 16919048 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 17.79 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 17.79 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Styrene | 17.79 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 17.79 | 19428831 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Vinyl Chloride | 17.79 | 12562636 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 1,2-dibromo-3-chloropropane | 25.36 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 25.36 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Butylated Hydroxytoluene | 25.36 | 1500032 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | captafol | 25.36 | 8441825 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 25.36 | 12104042 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 25.36 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | methyleugenol | 25.36 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 25.36 | 8985016 11606380 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 25.36 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 25.36 | 11731420 19196723 14580682 16827153 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 25.36 | 8985016 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 3.22 | 19453300 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 2.06 | 17453147 | |
| MESH:D008545 | Melanoma | Acridine Orange | 39.34 | 16814760 | |
| MESH:D008545 | Melanoma | Carboplatin | 39.34 | 16342250 11712820 12040289 16225601 | |
| MESH:D008545 | Melanoma | Carmustine | 39.34 | 12393984 | |
| MESH:D008545 | Melanoma | Cisplatin | 39.34 | 16248763 12883367 17761969 12393984 16809738 18176117 15577323 18332650 17023156 11135225 16432458 12374674 18505091 | |
| MESH:D008545 | Melanoma | Curcumin | 39.34 | 17885582 18462866 | |
| MESH:D008545 | Melanoma | decitabine | 39.34 | 17785578 16505122 | |
| MESH:D008545 | Melanoma | Dinitrochlorobenzene | 39.34 | 12202904 17334785 | |
| MESH:D008545 | Melanoma | docetaxel | 39.34 | 12417787 | |
| MESH:D008545 | Melanoma | Doxorubicin | 39.34 | 16827129 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 39.34 | 11746506 17992120 | |
| MESH:D008545 | Melanoma | Isotretinoin | 39.34 | 17237267 | |
| MESH:D008545 | Melanoma | Paclitaxel | 39.34 | 12025231 16342250 12040289 | |
| MESH:D008545 | Melanoma | Platinum | 39.34 | 16814760 | |
| MESH:D008545 | Melanoma | Platinum Compounds | 39.34 | 16814760 | |
| MESH:D008545 | Melanoma | resveratrol | 39.34 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 39.34 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Tamoxifen | 39.34 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Tretinoin | 39.34 | 16752155 | |
| MESH:D008545 | Melanoma | trichostatin A | 39.34 | 16505122 | |
| MESH:D008545 | Melanoma | Vinblastine | 39.34 | 15577323 17761969 16248763 15577320 16432458 12374674 18332650 18176117 16809738 18505091 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 12.16 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 12.16 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Vincristine | 12.16 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | 2-oxothiazolidine-4-carboxylic acid | 16.06 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 16.06 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 16.06 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 16.06 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 5.62 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 5.62 | 18411066 15451040 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 3.14 | 16940565 | |
| MESH:D001523 | Mental Disorders | Amitriptyline | 11.28 | 16856516 | |
| MESH:D001523 | Mental Disorders | Clomipramine | 11.28 | 16856516 | |
| MESH:D001523 | Mental Disorders | Doxepin | 11.28 | 16856516 | |
| MESH:D001523 | Mental Disorders | Haloperidol | 11.28 | 16856516 | |
| MESH:D001523 | Mental Disorders | Imipramine | 11.28 | 16856516 | |
| MESH:D008607 | Mental Retardation | Toluene | 3.02 | 9294310 | |
| MESH:D008654 | Mesothelioma | Asbestos | 10.87 | 16919927 18310086 16564556 18709470 16319530 | |
| MESH:D008654 | Mesothelioma | Atrazine | 10.87 | 1916698 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 10.87 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 10.87 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 10.87 | 15107826 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 3.16 | 17112576 | |
| MESH:D008679 | Metaplasia | Ozone | 3.77 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | 4-chloronitrobenzene | 4.84 | 3710033 | |
| MESH:D008881 | Migraine Disorders | Amitriptyline | 3.79 | 18803445 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.28 | 15792986 | |
| MESH:D019957 | Motor Skills Disorders | Toluene | 3.99 | 9294310 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 4.87 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 4.87 | 16757204 18986760 | |
| MESH:D052016 | Mucositis | Doxorubicin | 3.48 | 17415656 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 25.28 | 11468182 19417148 15949261 19549372 14977855 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 25.28 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | Capsaicin | 25.28 | 17505005 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 25.28 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 25.28 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 25.28 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 25.28 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 25.28 | 17049120 17164350 14749477 16267019 17935668 16490592 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 25.28 | 18172295 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 13.64 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 13.64 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 13.64 | 17962980 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 2.23 | 16239165 | |
| MESH:D009139 | Musculoskeletal Abnormalities | sodium arsenate | 3.64 | 18186108 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.34 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 6.84 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 6.84 | 19157545 16882708 19010910 18608210 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 6.84 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 9.48 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 9.48 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 9.48 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 9.48 | 16317513 16525036 17015251 17188708 17125593 16456233 | |
| MESH:D009203 | Myocardial Infarction | Vincristine | 9.48 | 17284715 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 5.26 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 5.26 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 4.78 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 4.78 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.45 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 3.17 | 17484760 | |
| MESH:D009224 | Myotonia Congenita | Quinine | 4.93 | 1896199 | |
| MESH:D009336 | Necrosis | Trinitrotoluene | 3.47 | 18551238 | |
| MESH:D009349 | Nematode Infections | Thiabendazole | 5.09 | 16402567 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 6.16 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 6.16 | 18495463 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 7.20 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 7.20 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 7.20 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 7.20 | 19393235 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.90 | 19410462 | |
| MESH:D009369 | Neoplasms | 2-butenal | 32.91 | 10626223 | |
| MESH:D009369 | Neoplasms | 2-hexenal | 32.91 | 10626223 | |
| MESH:D009369 | Neoplasms | Acrolein | 32.91 | 17329238 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 32.91 | 11141357 | |
| MESH:D009369 | Neoplasms | Carboplatin | 32.91 | 17925555 18854779 | |
| MESH:D009369 | Neoplasms | Cisplatin | 32.91 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 32.91 | 18854779 | |
| MESH:D009369 | Neoplasms | decitabine | 32.91 | 19116145 19470736 17925555 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 32.91 | 18239605 18600527 16928823 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 32.91 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 32.91 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 32.91 | 11559025 | |
| MESH:D009369 | Neoplasms | Thiotepa | 32.91 | 18854779 | |
| MESH:D009369 | Neoplasms | Tretinoin | 32.91 | 16946489 16594593 | |
| MESH:D009369 | Neoplasms | Vinyl Chloride | 32.91 | 11911487 | |
| MESH:D009374 | Neoplasms, Experimental | captafol | 15.30 | 8441825 | |
| MESH:D009374 | Neoplasms, Experimental | Captan | 15.30 | 8441825 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 15.30 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 15.30 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Toluene 2,4-Diisocyanate | 15.30 | 1670384 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 10.82 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 10.82 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 10.82 | 19189210 19196722 19200415 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 3.13 | 15738583 | |
| MESH:D009393 | Nephritis | Acrolein | 4.95 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 6.48 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Tetracycline | 6.48 | 9884423 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.48 | 16636307 16899518 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 2.84 | 16889571 15640375 | |
| MESH:D009410 | Nerve Degeneration | Acrylamide | 5.29 | 11264303 12387366 12387367 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 5.29 | 16893418 | |
| MESH:D009422 | Nervous System Diseases | Acrylamide | 3.83 | 12164553 12507653 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 5.36 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 5.36 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.29 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 12.15 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 12.15 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenate | 12.15 | 11749123 18186108 19446573 10525206 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 12.15 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 12.15 | 9142499 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.90 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Acridine Orange | 22.09 | 16814760 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 22.09 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 22.09 | 8761367 16115947 15176712 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 22.09 | 15555623 | |
| MESH:D009447 | Neuroblastoma | Isotretinoin | 22.09 | 17368321 | |
| MESH:D009447 | Neuroblastoma | Platinum | 22.09 | 16814760 | |
| MESH:D009447 | Neuroblastoma | Platinum Compounds | 22.09 | 16814760 | |
| MESH:D009447 | Neuroblastoma | Thiotepa | 22.09 | 8761367 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 10.85 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 10.85 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 10.85 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 10.85 | 17652729 | |
| MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 22.29 | 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 22.29 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 22.29 | 8761367 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Thiotepa | 22.29 | 12837982 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Vincristine | 22.29 | 12837982 | |
| MESH:D020078 | Neurogenic Inflammation | Capsaicin | 10.80 | 17961222 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 10.80 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 10.80 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.78 | 20387270 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 2.44 | 16436463 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 5.69 | 8291058 | |
| MESH:D009503 | Neutropenia | Vinblastine | 5.69 | 17378895 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | perfluorooctanoic acid | 3.67 | 9802331 | |
| MESH:D009669 | Nose Neoplasms | 1,2-dibromo-3-chloropropane | 4.74 | 9385384 | |
| MESH:D009765 | Obesity | Capsaicin | 5.80 | 19056576 | |
| MESH:D009765 | Obesity | Curcumin | 5.80 | 19297423 | |
| MESH:D009765 | Obesity | pirinixic acid | 5.80 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 5.80 | 20132043 19056576 | |
| MESH:D009784 | Occupational Diseases | 4-amino-2,6-dinitrotoluene | 15.98 | 14694615 | |
| MESH:D009784 | Occupational Diseases | Benzene | 15.98 | 17479406 15727169 17178637 15913788 17119257 16737584 15576619 15612468 15935809 | |
| MESH:D009784 | Occupational Diseases | Toluene 2,4-Diisocyanate | 15.98 | 8156442 3040596 12585506 18394133 6091945 6091946 11077013 | |
| MESH:D009784 | Occupational Diseases | Trinitrotoluene | 15.98 | 17852074 12819281 14694615 | |
| MESH:D009784 | Occupational Diseases | Vinyl Chloride | 15.98 | 12061072 | |
| MESH:D009845 | Oligospermia | 1,2-dibromo-3-chloropropane | 7.29 | 73955 12759094 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 7.29 | 16517039 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 3.67 | 15867366 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 3.06 | 17016548 | |
| MESH:D010024 | Osteoporosis | Curcumin | 4.54 | 18719352 | |
| MESH:D010024 | Osteoporosis | kaempferol | 4.54 | 16756079 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 6.11 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 6.11 | 17513867 | |
| MESH:D012516 | Osteosarcoma | marker/mechanism | 17152492 | ||
| MESH:D012516 | Osteosarcoma | Doxorubicin | 2.98 | 15930896 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 20.62 | 19769630 16624393 12452020 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 20.62 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 20.62 | 15464296 19769630 17225452 6897625 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 20.62 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 20.62 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 20.62 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 20.62 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 20.62 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 20.62 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 20.62 | 19331143 | |
| MESH:D010146 | Pain | Acetaminophen | 15.07 | 16870215 | |
| MESH:D010146 | Pain | Amitriptyline | 15.07 | 12798668 | |
| MESH:D010146 | Pain | Capsaicin | 15.07 | 17043245 16996476 17084039 17434803 19081190 18987195 | |
| MESH:D010146 | Pain | Clomipramine | 15.07 | 12798668 | |
| MESH:D010146 | Pain | Cyclophosphamide | 15.07 | 18093676 12161096 | |
| MESH:D010146 | Pain | Imipramine | 15.07 | 12798668 | |
| MESH:D010146 | Pain | Tretinoin | 15.07 | 16870215 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 39.22 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 39.22 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 39.22 | 17440100 19401701 19196508 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 39.22 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 39.22 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 39.22 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 39.22 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 39.22 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 39.22 | 16929163 16500647 19003803 15113037 | |
| MESH:D010190 | Pancreatic Neoplasms | Mitomycin | 39.22 | 15113037 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 39.22 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 39.22 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 39.22 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 39.22 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 39.22 | 19294695 | |
| MESH:D010195 | Pancreatitis | artemisinine | 5.95 | 17948936 | |
| MESH:D010195 | Pancreatitis | Methyldopa | 5.95 | 10484002 | |
| MESH:D010212 | Papilloma | cumene hydroperoxide | 11.98 | 12065085 17234724 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 11.98 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 11.98 | 16517061 15173996 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 11.98 | 12065085 18404319 8330346 18922899 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.92 | 19927285 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 6.40 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Atrazine | 6.40 | 17218051 | |
| MESH:D010300 | Parkinson Disease | Eugenol | 6.40 | 17329831 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 6.40 | 11181820 16140633 16510128 11445065 15824117 15451049 11124998 12911755 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 3.15 | 16190885 | |
| MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 9.38 | 20133375 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 9.38 | 12520081 | |
| MESH:D010391 | Pemphigoid, Bullous | Tetracycline | 4.10 | 11026799 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Acrylamide | 6.25 | 11510240 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 6.25 | 15464296 | |
| MESH:D010538 | Peritonitis | Ozone | 2.87 | 16369182 | |
| MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 9.06 | 11550810 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 9.06 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.82 | 17983394 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.56 | 15087411 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 9.53 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 9.53 | 17638057 | |
| MESH:D011014 | Pneumonia | Butylated Hydroxytoluene | 15.97 | 11893704 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 15.97 | 12224865 11605937 | |
| MESH:D011014 | Pneumonia | Ozone | 15.97 | 18007984 18929643 18381685 | |
| MESH:D011014 | Pneumonia | Paraquat | 15.97 | 12504350 | |
| MESH:D017285 | Polymyositis | Vinyl Chloride | 5.53 | 11642524 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Hexachlorobenzene | 6.92 | 9918132 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 6.92 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | marker/mechanism | 2563599 | ||
| MESH:D011230 | Precancerous Conditions | 1-phenylazo-2-naphthol | 12.51 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 12.51 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 12.51 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 12.51 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 5.10 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Vincristine | 5.10 | 21297632 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 21.45 | 18769834 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | perfluorooctanoic acid | 21.45 | 17132714 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Pesticides | 21.45 | 17938740 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 21.45 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 21.45 | 11118676 11399792 11222880 11896295 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 21.45 | 18042343 18220299 19015723 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 8.16 | 17616702 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 8.16 | 17616702 | |
| MESH:D017096 | Prion Diseases | Tetracycline | 4.10 | 10903871 | |
| MESH:D011469 | Prostatic Diseases | vinclozolin | 3.62 | 18220299 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 15538743 17173048 | ||
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 7.26 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 7.26 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 7.26 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 7.26 | 11398177 18769126 18156803 12497104 18226269 10851300 15129424 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 7.26 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | docetaxel | 7.26 | 19103299 18824434 16644109 16520278 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 7.26 | 16868541 16729912 16888761 15897917 15749863 18437689 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 7.26 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 7.26 | 18626508 19082440 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 7.26 | 17172428 17136230 16356831 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 7.26 | 14666653 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 7.26 | 14715546 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 7.26 | 16731767 15767336 17636462 17718901 17675339 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 7.26 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 7.26 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | sulindac sulfone | 7.26 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 7.26 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 7.26 | 19789329 18798265 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 7.26 | 15084515 | |
| MESH:D011472 | Prostatitis | vinclozolin | 3.62 | 18629315 | |
| MESH:D011507 | Proteinuria | Tretinoin | 2.40 | 16636307 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 3.17 | 12752131 | |
| MESH:D011595 | Psychomotor Agitation | Haloperidol | 3.67 | 11575062 | |
| MESH:D011596 | Psychomotor Disorders | Isotretinoin | 4.60 | 18769834 | |
| MESH:D011605 | Psychoses, Substance-Induced | marker/mechanism | 15729709 | ||
| MESH:D011618 | Psychotic Disorders | Haloperidol | 3.20 | 11575062 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.48 | 16723453 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.33 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | Toluene 2,4-Diisocyanate | 4.30 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 3.55 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 3.55 | 16324872 17997886 | |
| MESH:D011928 | Raynaud Disease | Vinyl Chloride | 4.84 | 16977343 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.84 | 18286688 15538739 18722050 16160472 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 9.95 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 9.95 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 9.95 | 17922066 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.25 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Capsaicin | 6.02 | 19211983 18460982 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 6.02 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 6.02 | 17520802 16314181 15827377 17058453 16317513 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 5.22 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 5.22 | 11700416 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 5.24 | 10835634 | |
| MESH:D012130 | Respiratory Hypersensitivity | Toluene 2,4-Diisocyanate | 5.24 | 20219652 7692837 16940033 | |
| MESH:D012135 | Respiratory Sounds | marker/mechanism | 18950799 | ||
| MESH:D012135 | Respiratory Sounds | Atrazine | 12.71 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 12.71 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Pesticides | 12.71 | 17119214 | |
| MESH:D012135 | Respiratory Sounds | Vehicle Emissions | 12.71 | 18950799 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.57 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Pesticides | 7.22 | 17119214 | |
| MESH:D012140 | Respiratory Tract Diseases | Toluene 2,4-Diisocyanate | 7.22 | 18447907 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 2.79 | 16458197 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 6.83 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 6.83 | 16116481 16283617 | |
| MESH:D012220 | Rhinitis | Toluene 2,4-Diisocyanate | 3.44 | 19050374 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Toluene 2,4-Diisocyanate | 3.96 | 12617775 15015336 | |
| MESH:D006255 | Rhinitis, Allergic, Seasonal | Toluene 2,4-Diisocyanate | 4.19 | 19075512 | |
| MESH:D012509 | Sarcoma | marker/mechanism | 17152492 | ||
| MESH:D012509 | Sarcoma | Curcumin | 12.89 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 12.89 | 15625365 15675481 16767912 17710206 17203757 18313854 | |
| MESH:D012509 | Sarcoma | Ifosfamide | 12.89 | 17710206 15625365 18313854 | |
| MESH:D012509 | Sarcoma | Vinyl Chloride | 12.89 | 12828392 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 19.16 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 19.16 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 19.16 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 19.16 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 19.16 | 14601052 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.48 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.21 | 16862918 | |
| MESH:D012559 | Schizophrenia | Haloperidol | 2.60 | 19369910 20107430 1830565 18513383 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 7.62 | 16636934 | |
| MESH:D012595 | Scleroderma, Systemic | Vinyl Chloride | 7.62 | 14979077 | |
| MESH:D012640 | Seizures | Ethanol | 6.01 | 9754883 | |
| MESH:D012640 | Seizures | Phenobarbital | 6.01 | 3137016 16876388 11442880 4039156 | |
| MESH:D012640 | Seizures | Toluene | 6.01 | 6431079 9294310 | |
| MESH:D012640 | Seizures | Trinitrotoluene | 6.01 | 18551238 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.51 | 6407741 | |
| MESH:D018805 | Sepsis | Curcumin | 2.94 | 18389075 | |
| MESH:D012871 | Skin Diseases | monomethylarsonic acid | 3.56 | 21378128 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 3.56 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 26.66 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | cumene hydroperoxide | 26.66 | 17234724 8532709 12065085 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 26.66 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 26.66 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 26.66 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 26.66 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 26.66 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 26.66 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 26.66 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 26.66 | 18404319 8985016 8330346 12065085 11807781 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 26.66 | 16467112 | |
| MESH:D012892 | Sleep Deprivation | Imipramine | 4.88 | 19798453 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Amitriptyline | 6.75 | 15341891 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Doxepin | 6.75 | 15341891 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 4.01 | 15464296 | |
| MESH:D012912 | Sneezing | Toluene 2,4-Diisocyanate | 4.19 | 19075512 19050374 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 7.87 | 17203757 16767912 15625365 | |
| MESH:D012983 | Soft Tissue Neoplasms | Ifosfamide | 7.87 | 15625365 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 2.97 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 4.20 | 16517039 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 2.74 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.69 | 12854658 | |
| MESH:D013163 | Splenomegaly | Trinitrotoluene | 3.91 | 15817613 | |
| MESH:D013272 | Stomach Diseases | captafol | 4.68 | 1765226 | |
| MESH:D013274 | Stomach Neoplasms | 1,2-dibromo-3-chloropropane | 21.31 | 3768853 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 21.31 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 21.31 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 21.31 | 2093021 20155912 | |
| MESH:D013274 | Stomach Neoplasms | Butylated Hydroxyanisole | 21.31 | 3581430 1399818 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 21.31 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 21.31 | 15958060 18396642 17522103 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 21.31 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 21.31 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | docetaxel | 21.31 | 16557585 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 21.31 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 21.31 | 19015929 17522103 19084572 16424979 17498489 18396642 16951190 17172411 15786421 18567086 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 21.31 | 18396642 18506536 | |
| MESH:D013274 | Stomach Neoplasms | styrene oxide | 21.31 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 21.31 | 17261132 | |
| MESH:D013274 | Stomach Neoplasms | Vinyl Chloride | 21.31 | 12562636 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 7.75 | 19188055 16631530 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 7.75 | 11906479 9211565 17918041 17189318 16755016 9562338 | |
| MESH:D013276 | Stomach Ulcer | Eugenol | 7.75 | 18543354 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 7.75 | 17135157 15255614 18237397 18193104 12787963 | |
| MESH:D020521 | Stroke | Acrolein | 5.26 | 16269634 | |
| MESH:D020521 | Stroke | Vitamin E | 5.26 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.28 | 16321402 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 3.07 | 9754883 | |
| MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 18.70 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 18.70 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Thiotepa | 18.70 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Vincristine | 18.70 | 12837982 | |
| MESH:D017180 | Tachycardia, Ventricular | Haloperidol | 3.46 | 20210726 | |
| MESH:D024801 | Tauopathies | Camptothecin | 7.51 | 16930453 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 7.51 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Capsaicin | 15.03 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 15.03 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | polyphenols | 15.03 | 17997062 | |
| MESH:D013733 | Testicular Diseases | Acrylamide | 10.15 | 15864552 | |
| MESH:D013733 | Testicular Diseases | phenethyl isothiocyanate | 10.15 | 15864552 | |
| MESH:D013733 | Testicular Diseases | Toluene | 10.15 | 10514026 10048760 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.39 | 17225452 15464296 | |
| MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 6.10 | 20133375 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 6.10 | 15821434 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 3.65 | 10850423 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.57 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 20.75 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 20.75 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 20.75 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 20.75 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 20.75 | 16010429 17909728 | |
| MESH:D013964 | Thyroid Neoplasms | Ethylenethiourea | 20.75 | 11940454 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 20.75 | 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 20.75 | 16026305 17045167 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 9.72 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 9.72 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 9.72 | 16051514 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 2.68 | 15213294 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 2.26 | 16040207 | |
| MESH:D001749 | Urinary Bladder Neoplasms | marker/mechanism | 12500666 | ||
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 33.03 | 1399818 15867355 15289314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 33.03 | 20435036 12973940 12845720 11780464 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 33.03 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Butylated Hydroxyanisole | 33.03 | 1399818 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cacodylic Acid | 33.03 | 15537745 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 33.03 | 12973940 17225452 15464296 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 33.03 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 33.03 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 33.03 | 19087683 17616700 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 33.03 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 33.03 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 33.03 | 16452187 16712894 11723127 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 33.03 | 8653321 16712894 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Vehicle Emissions | 33.03 | 11144890 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.95 | 18462866 | |
| MESH:D014581 | Urticaria | Acetaminophen | 1.79 | 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 17.24 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 17.24 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 17.24 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 17.24 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 17.24 | 16129372 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 17.01 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | Captan | 17.01 | 8441825 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 17.01 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 17.01 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 17.01 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 8.43 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 8.43 | 16752155 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 7.06 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Vinblastine | 7.06 | 15577323 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 3.12 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.26 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | captafol | 5.58 | 8441825 | |
| MESH:D014689 | Venous Insufficiency | coumarin | 4.44 | 12708602 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 9.90 | 17638931 17678736 16364871 17334414 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 9.90 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 9.90 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 4.01 | 18097624 | |
| MESH:D015837 | Vestibular Diseases | marker/mechanism | 18776599 | ||
| MESH:D014820 | Vitiligo | Tretinoin | 2.80 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 3.40 | 11897121 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.91 | 15886252 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.79 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 3.15 | 20213670 19894650 |
| Pathway ID | Pathway Name |
|---|---|
| REACT:13433 | Biological oxidations |
| KEGG:00982 | Drug metabolism - cytochrome P450 |
| KEGG:00480 | Glutathione metabolism |
| KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 |
| KEGG:05200 | Pathways in cancer |
| KEGG:05215 | Prostate cancer |
| Releated gene ID | Related gene Name |
|---|---|
| PA182 | GSTM1 |
| PA29024 | GSTM3 |
| PA29028 | GSTP1 |
| Releated disease ID | Related disease Name |
|---|---|
| PA444320 | Graft vs Host Disease |
| PA134850491 | Transplantation |
| PA165108938 | Respiratory distress syndrome in the newborn |
| PA162263534 | Ototoxicity |
| PA164925725 | Toxic liver disease |
| PA445062 | Neoplasms |
| PA446975 | Neurotoxicity Syndromes |
| PA443560 | Breast Neoplasms |
| PA447178 | Pulmonary Disease, Chronic Obstructive |
| PA165111675 | Drug Resistance |
| PA445013 | Myelodysplastic Syndromes |
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| PA443937 | Drug Toxicity |
| PA443622 | Carcinoma, Non-Small-Cell Lung |
| PA446108 | Colorectal Neoplasms |
| PA445204 | Ovarian Neoplasms |
| PA445254 | Parkinson Disease |
| PA444985 | Multiple Myeloma |
| PA443485 | Basal Cell Nevus Syndrome |
| PA444447 | Carcinoma, Hepatocellular |
| PA446171 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
| PA444010 | Emphysema |
| PA443899 | Diarrhea |
| PA445113 | Neutropenia |
| PA445742 | Stomach Neoplasms |
| PA444257 | Gastrointestinal Neoplasms |
| PA445301 | Peripheral Nervous System Diseases |
| PA444818 | Lung Neoplasms |
| PA445503 | Rectal Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA449167 | cyclosporine |
| PA164754818 | betamethasone |
| PA449247 | dexamethasone |
| PA164713176 | Platinum compounds |
| PA449412 | doxorubicin |
| PA130232992 | bevacizumab |
| PA451341 | sevoflurane |
| PA449780 | glutathione |
| PA450191 | lecithin |
| PA451668 | thiotepa |
| PA450761 | paclitaxel |
| PA451996 | azacitidine |
| PA451846 | valproic acid |
| PA451193 | pyrimethamine |
| PA449383 | docetaxel |
| PA128406956 | fluorouracil |
| PA448926 | chlorambucil |
| PA450526 | mitoxantrone |
| PA131889722 | telcyta |
| PA449014 | cisplatin |
| PA131285527 | oxaliplatin |
| PA449165 | cyclophosphamide |
| PA448803 | carboplatin |
| PA450085 | irinotecan |
| PA448492 | asparaginase |
| PA449177 | cytarabine |
| PA449212 | daunorubicin |
| PA449552 | etoposide |
| PA450198 | leucovorin |
| PA450379 | mercaptopurine |
| PA450428 | methotrexate |
| PA451100 | prednisone |
| PA451879 | vincristine |
| PA450354 | melphalan |
| PA448691 | busulfan |
| PA452621 | antineoplastic agents |
| PA452622 | antimetabolites |
| PA150481187 | folic acid analogues |
| PA452642 | podophyllotoxin derivatives |
| PA150481189 | taxanes |
| PA150481186 | topoisomerase I inhibitors |
| PA150481188 | vinca alkaloids and analogues |
| PA452604 | xenobiotics |
| PA448771 | capecitabine |
| PA164713220 | Pyrimidine analogues |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00143 | - | BSS Plus | Dietary supplement;Micronutrient |
| DB01242 | antagonist | Clomipramine | Antidepressive Agents, Tricyclic;Serotonin Uptake Inhibitors |
| DB01834 | - | (9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene | |
| DB01915 | - | S-Hydroxycysteine | |
| DB02633 | - | Cibacron Blue | |
| DB03003 | - | Glutathione Sulfonic Acid | |
| DB03686 | - | S-(P-Nitrobenzyl)Glutathione | |
| DB03814 | - | 2-(N-Morpholino)-Ethanesulfonic Acid | |
| DB04077 | - | Glycerol | Solvents;Cryoprotective Agents |
| DB04132 | - | S-Hexylglutathione | Enzyme Inhibitors |
| DB04339 | - | Carboxymethylenecysteine | |
| DB04412 | - | 1-(S-Glutathionyl)-2,4-Dinitrobenzene | |
| DB07849 | - | S-NONYL-CYSTEINE | |
| DB08370 | - | S-(4-BROMOBENZYL)CYSTEINE | |
| DB08518 | - | 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID |
| No data |
| No data |
| No data |